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GENERAL INTRODUCTION
We live in a world replete with numerous living organisms, each of which
acts as a veritable chemical factory in the production of specific molecules, or
metabolites, necessary for its well-being.Secondary metabolites are those
compounds created from living species that have no apparent vital function for
respiration, metabolism, or growth, but which may act in other important areas
such as defense or reproduction. Biomolecules whose uses to the organism are
unknown are classified as secondary metabolites because they are simply too
complex and represent too much investment of energy to be considered waste-
products. These secondary metabolites often exhibit marked effects on humans
or other living creatures, and their use in modern chemotherapy is prevalent.
The synthesis of secondary metabolites in the laboratory has proven
extremely beneficial in many ways.Molecular structure assignments are
confirmed, new and more potent drugs discovered, and large quantities of natural
products are produced for medicinal purposes which would never have been
possible before. This dissertation describes synthetic studies directed toward a
specific class of secondary metabolites known as nonadrides.
PartIdescribes an asymmetric synthetic approach to a long-known
nonadride, byssochlamic acid.It describes a brief history of the isolation,
characterization, and biosynthesis of the molecule, and provides a look at the two
previous synthetic strategies used to arrive at byssochlamic acid in racemic form.
Finally, results will be presented towards an asymmetric approach to the
molecule.2
Part II entails model studies on an approach to a recently discovered
nonadride, CP-225,917. Biological activities and synthetic model studies from
other laboratories will be discussed, followed by a description of the synthesis of
a model system for a novel entry into the core structure of the molecule.3
PART ONE: AN ASYMMETRIC APPROACH TO (-)-
BYSSOCHLAMIC ACID
CHAPTER 1
History and Background
Byssochlamic acid (1)1 and CP-225,917 (8)2 belong to a structurally
unique family of compounds known as nonadrides.3 These natural products were
isolated as early as 19311 and as recently as 1995.8 Nonadrides are mold
metabolites, some of which have toxic properties. All nonadrides contain a nine-
membered carbocyclic ring system fused to two five-membered anhydride
moieties. As of this writing, there are ten known natural nonadrides (Figure 1.1).
The most notorious of the nonadrides, rubratoxins A and B (7)4,5 are toxic
substances that have been implicated in the poisoning of livestock through
feedstuff which was shown to be infected with Penicilliumrubrum.6,7,9
Conversely, CP-225,917 (8) and CP-263,114 (9) show potentially useful
biological activities; both compounds inhibit squalene synthase, a critical enzyme
in the production of cholesterol.In addition, these compounds are potential
therapeutic agents for cancer treatment owing to their ability to inhibit farnesyl
transferase.
Byssochlamic acid was isolated in 1933 during an investigation into the
natural metabolites of a new Ascomycete, Byssochlamys fulva9 This organism
was notable due to its fairly frequent occurrence as a cause of spoilage among
processed fruits.Its spores were determined to be unaffected by the normal fruit
sterilizing process in which the maximum temperature attained exceeds 90°C.
After several weeks of incubation of the fungus on a synthetic medium, it was4
found that acidification of the mixture produced an ether-soluble precipitate.
Recrystallization of this solid from ether-benzene yielded pure byssochlamic acid.
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Figure 1.1: The Nonadrides
9: CP-263,1145
Similarities of byssochlamic acid (1) to the previously isolated glaucanic
acid' (3) were striking in that both possessed identical molecular formulas by
freezing point depression (C18H2006) and both titrated as tetrabasic acids.
Melting point comparison, however, showed the two compounds were distinct
from each other.Byssochlamic acid was also found to be toxic to mice via
intraperitoneal injection, the first nonadride to exhibit toxicity.
Characterization of byssochlamic acid was built upon degradative work by
Sutter" and Kraft12 on glauconic and glaucanic acids. With this background, the
research team of D.H.R. Barton at Imperial College, London, conducted its own
inquiries' into the constitutions of these acids as well as byssochlamic acid.
After extensive degradative and spectroscopic studies, Sutherland proposed the
general structure 1as one possibility for byssochlamic acid, excluding
stereochemistry, and then confirmed the assignment by an X-ray crystal structure
of its bis-p-bromophenylhydrazide 10.14 Finally, the absolute stereochemistry of
byssochlamic acid was determined by fission of the nine-membered ring to give
acidic fragments of known absolute configuration.15
10
Also presented in the same paper by Sutherland et al. were hypotheses
regarding the biogenesis of the nonadrides. While the authors primarily focused
on glauconic and glaucanic acids, the general scheme is applicable to6
byssochlamic acid as well.It was suggested these compounds may be derived
from two units having essentially identical carbon skeletons (Figure 1.2), and that
the anion of one could undergo dimerization with the other to form a nonadride.
Figure 1.2: Dimerization of Two C9 Units To Form a Nonadride.
These units, in turn, could be derived from an intermediate in a modified
citric acid cycle, derived from the condensation of oxaloacetic acid with a fatty
acid (Figure 1.3).This hypothesis was strengthened by precedent in the
biosynthesis of other microbial products.16
HO2C CO2H
oxaloacetic acid
HO2C0 H
HO2C
HO2C
Figure 1.3 Proposed Biosynthesis of C9 Units
Itis not inconsequential that Barton's research group studied the
photochemistry of byssochlamic acid at this point.It was found that irradiation
with ultraviolet light in tetrahydrofuran gave a saturated product they dubbed
"photobyssochiamic acid." Two possible structures were proposed for the photo7
product: 11 and 12. Analogs of the highly-strained compound 11 later became
critical intermediates in White's racemic synthesis of byssochlamic acid21 as well
as in efforts described herein toward an asymmetric synthesis of the compound.
It is, however, a curious fact that Barton was not able to pyrolyze 11 to give 1,
and for this reason he favored 12 as the structure of photobyssochlamic acid.
11 12
In 1972, Stork published a synthetic route to racemic byssochlamic acid,
representing the first total synthesis of a nonadride.17 Stork's strategy employs
two hydroquinone dimethyl ethers which serve a dual purpose. These groups act
not only as latent anhydride systems, but they are also sufficiently sterically
demanding to induce the correct cis relationship of the two alkyl chains across
the nine-membered ring. The Stork synthesis is convergent, and the central ring
is formed from ketone 15 and dichloride 18 via enolate dialkylation.The
synthesis begins as shown in Scheme 1.
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Beginning with 5,8-dimethoxy-2-tetralone (13),18 alkylation of its pyrrolidine
enamine with n-propyl iodide produced 14.Fragment 18 was made via lithium
aluminum hydride reduction of diethyl 3,6-dimethoxyphthalate (16), derived from
3,6-dimethoxyphthalic anhydride,' followed by treatment with concentrated
hydrochloric acid (Scheme 2).
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The coupling of 15 and 18 was accomplished using sodium hydride in
glyme at reflux for five hours to furnish the tetracycle 19 in 80% yield (Scheme 3).
Hydroxylamine treatment gave oxime 20 quantitatively, which was opened with
phosphorus oxychloride-pyridine to give approximately a 1:1 ratio of tricyclic
nitriles 21a and 21b. The yield of the desired 21a could be increased by
transformation of 21 b into the more thermodynamically stable 21a using p-
toluenesulfonic acid in refluxing xylene. Excess methyllithium in diethyl ether
presumably formed the unisolated imine 22, which was then subjected to Wolff-
Kishner reduction conditions' to produce 23 in 80% yield.
It is at this point that another important result is revealed with implications
for the work described in this dissertation. Compound 23, having only one chiral
center, was subjected to dissolving metal reduction with lithium in ammonia in
order to reduce the stilbene double bond (Scheme 4). Surprisingly, the reaction
yielded exclusively one diastereomer, compound 24, confirming a strong15 18
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preference of of the alkyl chains in this system toward the cis configuration over the
trans. This can be explained by the "U-shaped" geometry evident in the X-ray
crystal structure of 10 (Figure 1.4).Formation of the trans isomer would move
the propyl group into a serious eclipsing interaction with the anhydride residues.10
In the naturally present cis configuration both alkyl chains are directed away from
the anhydride moieties.
BBr3
CH2Cl2
23
Li / NH3
(80%)
25
Scheme 4
24
a) KMnO4 / glyme-H20
b) Pb(OAc)4 / Ac0H-H20
(13%)
1
Transformation of the two hydroquinone ethers into the anhydrides of
byssochlamic acid proved to be problematic. Methyl ether cleavage with boron
tribromide provided the bis-dihydroquinone 25 which was oxidized in a two-step
treatment with potassium permanganate and lead tetraacetate in aqueous acetic
acid, to give racemic byssochlamic acid (1) in a disappointing 13% yield.
Nevertheless, Stork's synthesis was relatively concise and convergent, and it
broke new ground in the area of nonadride chemistry.
In a later approach,21 White and co-workers published a unique synthesis
of byssochlamic acid and also confirmed the higher stability of its trans isomer in
both theory and practice. MM2 calculations predicted the cis isomer to be more
stable than the trans by ca. 3.8 kcal/mol. Further, it was shown that treatment of11
byssochlamic acid with base under conditions which led to formation of a sodium
enolate resulted in no isomerization to the trans compound.
Figure 1.4 X-ray Crystal Structure of 10.
With this information in hand, the White group published a synthesis which
utilized the natural photoreactivity of byssochlamic acid discovered by
Sutherland, employing a [2+2] photoaddition-cycloreversion to arrive at the target
molecule via an analog of 11. This convergent approach couples diol 35 and
diacid 31 to form the substrate for photochemistry.
Formation of diacid 31 (Scheme 5) was also accomplished by a [2+2]
photoaddition. A mixture of 1-pentene and bromomaleic anhydride was irradiated
in the presence of a sensitizer, then treated with aqueous sodium carbonate to
give a mixture of bicyclic diacids 28. Treatment with diazomethane, followed by12
1,8-diazabicyclo[5.4.0]undec-7-ene induced dehydrobromination, afforded the
cyclobutene dimethyl ester 30.This compound was then saponified with
aqueous lithium hydroxyide in tetrahydrofuran to provide the diacid 31.
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Scheme 5
Acylation of 4-ethylcyclohexanone with sodium hydride and dimethyl
carbonate gave the p-keto ester 32 (Scheme 6). This was dibrominated and then
subjected to a Favorski rearrangement to yield the cyclopentene dimethyl ester
34.Finally, treatment with the "ate" complex of diisobutylaluminum hydrides
provided diol 35.
Coupling of 31 and 35 to form the diolide 36 was accomplished using
Steglich-Keck conditions24 of dicyclohexylcarbodiimide, 4-dimethylaminopyridine,
and the hydrochloride salt of 4-dimethylaminopyridine (Scheme 7).Irradiation ofNaOMe
NaH, (Me0)2C0
Me0H
(37%, 2 steps) (62%)
benzene
(86%)
Me02
hexane -TH F
34
Scheme 6
33
HO OH
35
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36 in dilute solution afforded the highly-strained structure 37 which, when
refluxed in toluene for several hours, opened quantitatively to produce the bis-
butenolide 38 as a mixture of the cis and trans diastereomers. Saponification of
the bis-lactone with lithium hydroxide in aqueous dioxane, followed by potassium
permanganate oxidation with acidic work-up afforded byssochlamic acid 1 as a
single, cis diastereomer.31 + 35
DCC, DMAP, DMAPHCI
./
37
CHCI3
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A
toluene
(100%)
38
Scheme 7
36
a) LiOH / H20-dioxane
b) KMnO4
14
hv
C H 2Cl2
(63%)
c) HCI (aq)
(37%)
1
Again, the propyl chain is seen to show a marked preference for cis over
trans configuration in this system. Presumably, epimerization occurred during
conversion of 38 to 1 to give only the more stable natural diastereomer.15
CHAPTER 2
Results and Discussion
As described in the previous chapter, White's successful route to racemic
byssochlamic acid was based on the photoaddition-cycloreversion metathesis of
diolide 36. In turn, 36 was made in convergent fashion from diacid 31 and diol
35. Modifying this approach to render it asymmetric would in theory require three
changes (Figure 2.1). These are, first, a method for synthesis of the chiral diacid
39, second, a process for desymmetrization of diol 40 by differentiation between
/
0
41
1
40
Figure 2.1: Asymmetric Route to Byssochlamic Acid Based on White's Approach16
its alcohols, and third, a routine for directed and stepwise coupling of 39 with 40
to produce 41 in homochiral form as the precursor for photocyclization.
Production of a chiral, differentiated cyclopentene diol 40 began from
dimethyl ester 34.21Reaction of 34 with porcine liver esterase in a pH 7
phosphate buffer system gave cleanly one product, the optically active acid 42
(Scheme 8).
Me02 CO2Me
34
porcine liver esterase
pH 7 buffer
H20-acetone
(100%)
Scheme 8
Me02C C 02H
42
Effort expended to assign an absolute configuration to 42 was
considerable. The carboxylate salts of 42 with (R)- and (S)-phenethylamine were
made (Scheme 9), but formed poorly defined needles which were inadequate for
X-ray crystallographic analysis.
VMe02 CO2H
RANH2
Et20
42 (-80%)
Scheme 9
Me02CC OF2j
43
N H3+
Attempts to esterify 39 with (R)-binapthol (Scheme 10) were also
unrewarding.CyMe02 CO2H
42
a) cyanuric chloride, Et3N
Or
DCC, DMAP
Scheme 10
No desired product
17
Brucine, phenylalaninol, and imidazole were all used as amine bases for
carboxylate salt formation from 42, but all gave poor or "clumped" crystals.
Amide derivatives of 42 were also prepared. The (S)-phenethylamine
amide 44 was formed by reaction of 42 with cyanuric chloride and triethylamine
in acetone, followed by addition of (S)-phenethylamine (Scheme 11), but was
found to be an oil.Saponification of 44 with lithium hydroxide in tetrahydrofuran-
water gave the carboxylic acid 45 in quantitative yield. Compound 45 formed
crystals that were needle-like and again were unsuitable for X-ray analysis.
M e02 CO2H
42
LiOH
THE -H2O
(100%)
a) cyanuric chloride, Et3N
H 02
b)
PI-N H2
45
(42%)
NH
....*
Ph
Scheme 11
Me 02
4418
Modification of 42 by esterification of the carboxylic group was also
explored. Benzylation was attempted via several routes but all were unsucessful
(Scheme 12).
Me02 CO2H
42
a)
N SyCI
0
or
DCC, DMAP
b) BnOH
Scheme 12
No desired product
However, treatment of 42 with isobutylene and concentrated sulfuric acid
in dioxane yielded the tert-butyl ester 46 in 89% yield (Scheme 13). Although 46
was not crystalline, saponification of this diester using lithium hydroxide in
tetrahydrofuran-water gave the crystalline carboxylic acid 47 in 97% yield.
Me02 CO2H
,H 2S 04 (con.)
dioxane
H02 CO2t-Bu
Me02C CO2tau
46
-02 CO2t-BU
Ph,,NH3+
47 48
Scheme 13
LiOH
THE -H20
(97%)19
Recrystallization of 47 from diethyl ether, followed by reaction with (S)-
phenethylamine, gave the carboxylate salt 48. Using hexane-chloroformvapor
diffusion crystallization, fine needle-like crystals were grown from 48; thesewere
analyzed by X-ray diffraction which provided the absolute configuration of the
series of ethyl cyclopentene compounds 42, 46, 47, and 48 (Figure 2.2).
Carboxyiate 48 was found to possess (S)-configuration. Since, in the conversion
of 42 to 48 the acid-ester functionalities had been reversed (see Scheme 13), 42
was assigned as having (R)-configuration.
Figure 2.2: ORTEP Representation from X-ray Structure of 48.
Esterase product 42 showed only one peak on three different chiral HPLC
columns (chiralcel OD, chiralcel AD, and chiralcel 0J). In addition, derivatives of
42 with optically active materials (cf. 44, 45) showed only one diastereomer by
both carbon and proton NMR spectra. From these observations, 39 was judged
to be optically pure.20
Now that the configuration of 42 was known to be (R), it remained to
selectively reduce the carboxyl groups sequentially to the alcohol level.
Reduction of 42 with diborane in tetrahydrofuran proved troublesome and gave a
mixture of products. A model system for this reduction was provided by the
reaction of methanol with maleic anhydride (49) which gave 50 (Scheme 14). As
with 42, attempts to selectively reduce 50 were in large part unsuccessful, giving
multiple products. However, it was possible to isolate the lactone 51 in low yield.
0
q:
49
Me0H
(100%)
,....0O2H
NCO2Me
B 2H6
THE
(26%)
QD
50 51
Scheme 14
0
At this point the synthetic strategy was revised in a seemingly minor way
which in fact had important consequences.It was thought that the two carboxyl
groups in cyclobutene 39 would be farther apart than those in cyclopentene 42
due to the greater dihedral bond angle, and that their diminished interaction could
CO2Me
CO2 H
42
-60°
39
> 60°
Figure 2.3: Comparison of Dihedral Bond Angles Between 42 and 3921
reduce problems with selective reduction (Figure 2.3).For this reason, the
synthetic route was modified as depicted in Figure 2.4.
53
1
Figure 2.4: Revised Route to ()-Byssochlamic Acid
In principle, similar photochemistry could be applied to 53 to that used with
41, and thermal metathesis followed by oxidation could provide the same
product, 1.Since ()-42 was already in hand, the effort was focused on
synthesis of the homochiral cyclobutene 52. The hope was that 52 could be
prepared in enantiopure form as had been accomplished with 42.
Initially, asymmetric induction in the [2+2] photoreaction between 1-
pentene and bromomaleic anhydride was explored as a route to optically
enriched 52 (Scheme 15).The plan involved reaction of 26 with a chiral22
binaphthol 54, followed by lactonization, which would give homochiral diolide 56.
This substrate would be expected to undergo photocyclization with 1-pentene in
a highly asymmetric manner to yield photoadduct 57.
26
+
54
0
56
hv
--..--'--.-
Scheme 15
55
0
0
57
Application of this method, however, was impractical for several reasons.
In contrast to the situation with other alcohols which react readily with maleic
anhydrides, the steric demands and phenolic character of 54 make it a relatively
poor nucleophile.25 While methanol reacted completely with 26 in chloroform at
room temperature to yield the free acid 58 (Scheme 16), a mixture of 26 and 54
showed no appreciable reaction after several hours at reflux. Common amine
bases (triethylamine, pyridine, diisopropylethylamine) reacted with 26 to give
dark brown precipitates which were unreactive toward alcohols. Exposure of 26
to sodium phenoxides produced only a small amount of the desired product in
the case of phenol, and no product at all in the case of binapthol.23
In addition to difficulties with nucleophiles, there were problems with the
electrophile.Bromomaleic anhydride (26) is known to be succeptible to
nucleophilic attack at all four carbons.26Lactonization to 56 may even be
hampered by competing formation of an internal acetal (Figure 2.5).27 All of the
above may explain why repeated attempts to produce 56 were unsuccessful or
resulted in the formation of multiple products.
Figure 2.5: Internal Acetal Formation
Next, the feasibility of using the ring-opened monoester 55 as a
photosubstrate was investigated. Monomethyl bromomaleate 58 was prepared
by treatment of 26 with methanol and was irradiated with 1-pentene for several
hours in the presence of a sensitizer (Scheme 16).Starting material was
recovered in almost quantitative yield, suggesting that the closed-ring anhydride
structure is necessary for photoreactivity.
26
Me0H
(quant.)
02H
CO2Me
58
1-pentene, hv, sens.
Scheme 16
No [2+2]
reaction24
Finally, optical resolution was attempted on the racemic dicarboxylic acid
31 through crystallization of salts prepared with enantiopure bases.Thus,
crystallization of carboxylate salts of 31 were attempted with brucine, strychnine,
and (R)- and (S-phenethylamine in various solvent systems was studied, but
yielded no optically active product.
The disappointing outcome from the chemical approaches described
above for acquiring homochiral 52 led us to consider enzymatic means for this
purpose.Dimethyl cyclobutene dicarboxylate 30, an intermediate in White's
synthesis (Scheme 5), was treated with porcine liver esterase for 3.5 hours in a
pH 7 phosphate buffer system. The result was formation of racemic carboxylic
acid 59 in almost quantitative yield (Scheme 17). Enzymatic treatment of diester
30 had cleanly selected one of the two ester functions for hydrolysis but had
exhibited no enantioselection.
0 Me porcine liver esterase CO2H
pH 7 buffer
CO2Me H20-acetone CO2Me
30 (98%) 59
Scheme 17
The formation of racemic product 59 from an enzymatic reaction was
suprising and initially disappointing.This conclusion, however, is reasonable
when it is appreciated that all of the racemic diester was converted to monoacid.
No other products were isolated except a small amount (<5%) of the propyl
regiomer. Optical rotation measurements taken at various concentrations were
uniformly zero.25
After reflection, however, this result came to be viewed in a more positive
light.While showing no stereoselectivity, the esterase clearly exhibited
regioselectivity in its interaction with 30. One problem in the synthesis of 52,
namely differentiation between the carboxyl groups of 30, had been overcome in
this enzymatic process.
But this result raised an intriguing question regarding the structure of 59.
Which of the two methyl esters had been hydrolyzed? The difficulty of answering
this deceptively simple question becomes apparent with analysis.The two
possible structures, 59a and 59b (Figure 2.6), would have very similar NMR
spectra. Owing to the tetrasubstituted double bond in the four-membered ring,
coupling information from COSY and HETCOR experiments were unhelpful.
HMBC experiments which showed a weak coupling between protons at C5 with
the Cl ester carbonyl, suggested 59b as the more likely structure.
4
02H
6 J 6
2C 02Me 7 3CO2H
1 10 st 4
1 10
O2Me
59a 59b
Figure 2.6: Two Possible Products from the Esterase Hydrolysis of 30.
This was encouraging, but this finding alone was deemed inconclusive
evidence for two reasons.First, the coupling was so weak (see Fig 2.7) it was
debatable whether there was actually a coupling or simply noise.Secondly,
assuming that coupling was present, HMBC experiments are known to show little
difference in the magnitude of coupling between two bonds as compared with26
Figure 2.7: HMBC Spectrum of 5927
three bonds. The hydrogens at C5 could be coupled to Cl through three bonds
as in 59b, or to C1 through four bonds as in 59a.
Attempts to make a crystalline derivative of 58 in order to acquire an X-ray
crystal structure of the compound proved to be even more difficult than for the
cyclopentene counterpart 42.Although a chiral derivatizing agent was not
necessary in the case of 58, most products were either oils or formed poor
quality crystals.Carboxylate salts were produced with benzylamine,
benzimidazole, and phenethylamine, all of which gave very small, needle-like
crystals. The 3,5-dinitrobenzyl ester 60 was obtained, but was an oil (Scheme
18).
02H a) KOH / DMPU -EtOH
59
OMe
(90%)
NO2
Scheme 18
Other Other clues to the structure of 59 were forthcoming, however.The
chemical shifts of the cyclobutene protons in 59 were compared with those of the
cyclobutenedicarboxylic acid 31 and the dimethyl ester 30 (Table 3.1).It is clear
from this analysis that the protons HA and HB in the esterase product 59
resemble those in which the propyl group is adjacent to the carboxylic acid (59b)
rather than the ester. On this basis, it was considered probable that enzymatic
hydrolysis of dimethyl ester 30 had produced 59, albeit in racemic form.28
Table 2.1 Chemical Shifts of Protons HA and HB in 30, 31, and 59 (CDCI3)
30 (R = Me) 31 (R = H) 59
HA
HB
82.78
8 2.25
52.89
8 2.37
52.87
8 2.35
The syntheses of (±)-byssochlamic acid published by Stork and White
implied that setting the configuration of the propyl group in 52 was in fact not
mandatory since the center at C13 could be epimerized at a late stage in the
synthesis to give the natural stereoisomer. The synthesis therefore proceeded
toward a racemic form of 52 with the intention of effecting subsequent
equilibration of the center bearing the propyl substituent.
Selective reduction of the carboxylic acid of 59 was found to be more
difficult than had been anticipated. Table 2.2 summarizes reduction efforts on
59, which was finally achieved by using ethyl chloroformate and triethylamine to
form the (unisolated) acyl carbonate, followed by reduction with sodium
borohydride in water. This procedure afforded the hydroxy ester 60 in 83% yield.
Although itis a primary alcohol, hydroxy ester 61 was unexpectedly
sluggish toward protection.For example, treatment of 61 with tert-
butyldimethylsilyl chloride, triethylamine, and 4-(dimethylamino)pyridine in29
dichloromethane at room temperature for 24 hours resulted in only 8%
conversion to 62. Likewise, heating 61 in dimethylformamide in the presence of
tert-butyldimethylsilyl chloride and imidazole for 24 hours produced no significant
amount of the silylether.Finally, tert-butyldimethylsilyl trifluoromethane-
sulfonate and 2,6-lutidine in dichloromethane at 0°C transformed 61 to 62 in
quantitative yield (Scheme 19).Reduction of the resulting ester with
diisobutylaluminum hydride in hexanes-dichloromethane furnished the desired
alcohol 63 also in quantitative yield.
Table 2.2 Conditions and Results for Attempted Reduction of 59 to 62
02H OH
O2Me CO2Me
59 61
Reagent Result Yield of 62
borane-THF, 0° - rt varied, multiple products 7-39%
borane-DMS, 0°rt multiple products 25%
NaBH4, 12, no desired product
LiBHEt3, THF, -78°rt no desired product
HOBT, DCC, THF, then NaBH4 low yield 21%
EtO2CCI, Et3N, then NaBH4 favorable 83%
At this point, further data became available that reinforced the structural
assignment made to 59.Upon reduction of the carboxylic acid of 59, the30
cyclobutene methylene protons at C5 moved upfield 0.35 ppm whereas the
methine proton at C6 moved less than 0.1 ppm. This is consonant with structure
59b, since removal of the deshielding effect of the carboxylic acid would be
expected to cause an upfield shift of the methylene protons of this magnitude.
a) EtO2CCI, Et3N / THE 0°C
b) NaBH4 / H2O
(83%)
OT BS
DI BAL-H -78°C
CO2Me hexane CH2Cl2
(100%)
O HTBSOTf, 2,6-lutidine
CO2Me 0°C, CH2Cl2
61 (100%)
Scheme 19
63
With both the acid 42 and alcohol 63 now in hand, coupling was carried
out to create the first of the two ester linkages required for diolide 53. This was
accomplished using dicyclohexylcarbodiimide and 4-(dimethylamino)pyridine in
diethyl ether-chloroform and produced the diester 64 in 86% yield.
63
OTBSme02 ,CO2H
OH
42
DCC, DMAP
Et2O-CHC13
(86%)
Scheme 20
OTBS
0 CO2Me
6431
Unfortunately, the task of selectively cleaving the methyl ester of 64 while
leaving the cyclobutenylmethylene ester intact proved to be insurmountable. The
reactivities of the two ester moieties were essentially indistinguishable by most
methods of cleavage investigated (Table 2.3). Where selectivity was achieved, it
was in the undesired sense, the methyl ester being retained while the ester
linkage of 64 was fractured.
Table 2.3 Conditions and Results for Attempted Cleavage of 64 to 65
64 65
Reagent Result
LiOH / THE -H20 unselective saponification
Ba(OH)2.8H20 Me0H-H20 unselective saponification
TMSI / CHCI3, then H2O recovery of 42
The difficulties with 64 made it necessary to replace the methyl ester of 42
with a different ester that could be chemically distinguished from the
cyclobutenylmethylene ester in 64. Having tert-butyl ester 47 in hand, it was
decided to couple this compound to 63 with the intention of selectively cleaving
the tert-butyl ester in the presence of the cyclobutenylmethylene ester.In fact,
this chemistry proved to be straightforward. Ester formation of 47 with 63 was32
achieved under the conditions used previously, so that when the carboxylic acid
and alcohol were mixed in the presence of dicyclohexylcarbodiimide and 4-
(dimethylamino)pyridine in chloroform-diethyl ether the ester 66 was formed in
high yield (Scheme 21).For purification purposes, crude 66 was next treated
with tetra-n-butylammonium fluoride in tetrahydrofuran to furnish alcohol 67
which was isolated in 72% yield over two steps.Treatment of 67 with
trifluoroacetic acid in dichloromethane at room temperature rapidly cleaved the
tent -butyl ester while leaving the second ester linkage intact to give carboxylic
acid 68 in quantitative yield as a mixture of diastereomers.
63
OTBS
OH +
H 02
47 (86%)
66
(72%, 2 steps)
67
Scheme 21
(100%)
68
With 68 now available, lactonization was explored as a means for
acquring the required diolide 69.Yamaguchi's method,23 using 2,4,6-
trichlorobenzoyl chloride and triethylamine in tetrahydrofuran followed by reflux
with 4-(dimethylamino)pyridine in toluene, afforded 69 in 44% yield (Scheme 22).
Like 66-68, the diolide was initially presumed to be a mixture of two epimers33
resulting from the fact that 63 is racemic, but no evidence of this was seen by
proton or carbon NMR. An explanation for the formation of a single stereoisomer
of 69 could involve a large kinetic difference in cyclization rate between the two
diastereomers of 68, leading to only one of the two possible products, although
none of 68 was recovered from the reaction.
2,4,6-trichlorobenzoyl chloride,
Et3N , THF; DMAP, toluene, A
68
(44%)
Scheme 22
O
69
\
It was now possible to address the question whether 69 would be
photochemically reactive in a manner similar to 36, the photosubstrate in White's
racemic synthesis of byssochlamic acid.Diolide 69 was irriadiated with a 450
Watt Hanovia mercury lamp under various conditions, but yielded no desired
product (Table 2.4).
Initial experiments were carried out under the same conditions used to
effect photocycloaddition of 36, but these only returned starting material. Other
solvents were then investigated.Toluene (run 2) also gave back starting
material, whereas acetonitrile (run 6) resulted in degradation of the substrate.
The quality of both the source lamp and the glassware was considered; neither a
new lamp nor different photochemical apparatus led to useful results (runs 8, 9).
When benzophenone was employed as a photosensitizer, starting material was
degraded at a much faster rate than without the sensitizer (run 10).Finally, in34
order to irradiate with wavelenghts below 300 nm, a quartz apparatuswas
employed with a CorexTM filter. This did not return 69as other experiments had
done, but produced only dark colored, unisolable, polar material.
Table 2.4 Conditions and Results for the Attempted Cycloaddition of 69 to 70
as
hv
-7o
Run Solvent Conditions Time Recov.
69
1 dichloromethane 4 h 99%
2 toluene sealed tube 19 h 99%
3 dichloromethanesealed tube 2 h
4 methanol 1 h 75%
5 methanol 5 h 99%
6 acetonitrile 3 h 75%
7 methanol 4 h 99%
8 methanol new lamp 4 h 97%
9 methanol new chamber 4 h 99%
10 methanol photosensitizer 4 h 38%
11 dichloromethane 2 h 99%
12 dichloromethaneCorex filter 1 h35
These negative results were unanticipated and curious.In order to verify
that the photochemical techniques being used were not responsible for the failure
of 69 to undergo cycloaddition, White's diolide 36 was resynthesized according to
the original procedures. When subjected to irradiation in dichloromethane, 36
underwent [2+2] addition under the conditions used with 69 above and
cycloadduct 38 was isolated after thermal cycloreversion in a yield similar to that
reported.
Subsequently, conformational analysis of diolides 36 and 69 revealed
significant differences in molecular geometry that could explain the lack of
reactivity of 69. The smaller bond angle the between carbonyl-olefin bonds of 69
forces the spa ring oxygens closer together and twists the carbon-oxygen double
bonds slightly out of the plane containing the cyclopentene double bond. Figure
2.8 shows views of 36 and 69 along the axes of the double bonds after geometry
36 69
Figure 2.8: AM1 Minimal Energy Conformations of 36 vs. 6936
optimization using an AM1 computation.Itis possible that much of the
conjugation in 69 is lost whereas 36 retains good n-overlap of the cross
conjugated system.This disruption of conjugation would explain the lower
reactivity of 69 as a photosubstrate.
(
69
36
Figure 2.9: Ultraviolet Spectra of 36 vs. 69.37
In addition, the ultraviolet spectra of 36 and 69 were compared and found
to be quite revealing (Figure 2.9). The ultraviolet absorption of 69 diminished to
nearly zero near 300 nm, whereas that of 36 was appreciable at 350 nm. Thus,
the extinction coefficient of 36 measured at 313 nm was 16,000; but that of 69
was a mere 500.This would explain why 69 was less reactive photochemically
and resisted cycloaddition under the conditions used to photocyclize 36.
With this second route now closed and only 36 being a photochemically
reactive substrate, efforts to reach this diolide in asymmetric form were renewed.
Having learned that selective reduction of conjugated acid-esters was possible
from studies directed toward 62, reduction of the cyclopentene 42 was now re-
addressed in a much more successful fashion (Scheme 23). Treatment of 42
with ethyl chloroformate and triethylamine in tetrahydrofuran at 0°C, followed by
reduction with sodium borohydride in water and buffered work up conditions,
produced the alcohol 71 in much improved yield. Alcohol 71 was protected in
95% yield to afford silyl ether 72, followed by reduction with diisobutylaluminum
hydride which gave the requisite alcohol 73.
ymeo2 o2H
42
Me02
a) EtO2CCI, Et3N / THE 0°C
Me02 OTBS
b) NaBH4 / H2O
OH
TBSOTf, 2,6-lutidine
0°C, CH2Cl2
(90%) (95%)
71
DIBAL-H -78°C
hexane-CH2Cl2
OyH OTBS
(80%)
72 73
Scheme 2338
With the knowledge already in hand that a methyl ester was not a suitable
means of protecting the carboxyl group of the cyclobutene component, a tert-
butyl ester was prepared in two steps from 59 (Scheme 24). Esterification of 59
by reaction with isobutylene and sulfuric acid in dioxane gave the diester 74 in
good yield.The methyl ester was then saponified with lithium hydroxide in
tetrahydrofuran-water to provide the carboxylic acid 75.
H2SO4 (con.)
dioxane
(70%) 74
02tBu
O2Me
Scheme 24
LiOH
THE -H2O
(88%)
02t-Bu
CO2H
75
Esterification of of 73 with 75 using dicyclohexylcarbodiimide and 4-
(dimethylamino)pyridine was immediately successful but gave unimpressive
yields of 76.However, when 73 and 75 were coupled using 1-(3-
dimethylaminopropy1)-3-ethylcarbodiimide hydrochloride (EDCI) and 4-
(dimethylamino)pyridine in dichloromethane the desired ester 76 was obtained in
a much improved 76% yield (Scheme 25).Deprotection of the silyl ether was
accompanied by some formation of unisolable, polar material, but nevertheless
afforded the free alcohol 77 in acceptable yield.
The synthesis now required two steps to form a diolide whose
photoreactivity was already established.These two processes were to be
removal of the tert-butyl ester in the presence of the cyclopentenylmethylene
ester and cyclization.Both steps were judged to have good precedent in the
very similar systems described above. Regardless of these similarities, however,73
TBAF
THE
(58%)
OTBS
+
CO2t-BuEDCI, DMAP
C HCI3
O
77
Scheme 25
39
77 showed vastly different reactivity compared to its isomer 67. Table 2.5
outlines reactions which were attempted for removal of the tert-butyl group from
77, and shows that none were successful.
Thus, treatment of 77 with trifluoroacetic acid in dichloromethane resulted
in decomposition accompanied by a characteristic deep purple color.In fact, a
variety of conditions employed to accomplish the transformation of 77 to 78 either
led to polar, unisolable decomposition products, to the dicarboxylic acid 31, or
resulted in no reaction.
At present, it is unclear whether the failure to convert 77 to the free acid
78 is a function of the conditions chosen or whether the product 78 is extremely
unstable and, upon formation, rapidly decomposes.In light of the fact that so
many different conditions which effected reaction resulted in the same observed
outcome, the latter hypothesis is not without merit.In any case, it seems
reasonable to assign the difficulty with 77 to the cyclobutene ring, since removal
of the tert-butyl ester has been easily and cleanly achieved on cyclopentene 67.Table 2.5 Conditions and results for attempted deprotection of 77
77 78
40
Conditions Results
TFA / CH2CI229
HF / MeCN
p -TsOH / toluene
TMSI / MeCN
KOtBu / THF
TMSOTf, 2,6-lutidine / THF31
HCI / THF
formic acid
acetic acid
decomposition
decomposition
decomposition
diacid 31 (unselective)
diacid 31 (unselective)
decomposition
decomposition
complex mixture
no reaction
Further analysis, however, reveals that the disappointing outcome with 77
cannot be due exclusively to the cyclobutene moiety.For example, those
reaction conditions which led to unselective ester hydrolysis did not produce
decomposition products.Rather, they cleanly produced the cyclobutene
dicarboxylic acid 31.It is therefore conceivable that the tert-butyl ester could be
removed uneventfully if the other cyclobutene carboxyl group is a free acid, a
circumstance which obviously cannot be taken advantage of here.41
To answer thequestionofjust how much ofarolethe
cyclopentylmethylene ester plays in the decomposition of 77, tent -butyl ester 42
was subjected to treatment with trifluoroacetic acid in dichloromethane.
Cleavage of 42 under these conditions was rapid and complete, and cleanly
yielded carboxylic acid 59 in quantitative yield (Scheme 26).The same
experiment was run on alcohol 73, and resulted in a routine deptrotection to the
diol 35 with no apparent decomposition (Scheme 27).
CO2 t-Bu
CO2M e
73
TFA
CH2Cl2
(100%)
Scheme 26
The conclusion reached from the foregoing results is that decomposition
of 77 is a property inherent to this specific compound, and is presumably a
consequence of the interaction of both cyclopentenyl and cyclobutenyl moieties.
OTBS HO OH
TFA
CH2Cl2
(89%)
73 35
Scheme 27
The mechanism of decomposition is still unknown.
In summary, the asymmetric approach to ()-byssochlamic acid described
above encountered insurmountable barriers. Characterization of tetrasubstituted,42
olefinic compounds which were the products of enzymatic transformations was
difficult.Also, the synthetic route met an impassable obstacle in each of three
different approaches. The first problem was associated with the inability to
remove a methyl ester in the presence of a primary allylic ester.In a modified
approach, a diolide was synthesized, only to discover that it was unreactive to
the photochemistry required to transform it to ()-byssochlamic acid. The final
route faced the problem of an advanced intermediate which underwent
decomposition under all conditions used to deprotect it.This last failure occurred
notwithstanding the fact that similar deprotection was achieved on a comparable
system prepared earlier in our laboratories.
Nevertheless, several findings from this research are noteworthy and
deserve further study. The use of porcine liver esterase on a racemic dimethyl
ester as a successful and practical means of regioselective hydrolysis stands out.
Almost all of the compounds synthesized are new, as evidenced by the fact that
none could be found in the literature for optical rotation and spectral comparison.
And the photochemical results highlight the subtle effect which molecular
geometry can play in defining chemical reactivity.
With regard to the future of this asymmetric synthesis of ()-byssochlamic
acid, there still remain several options. The bis-anhydride 82 is an attractive
substrate for irradiation since it would yield byssochlamic acid (1) directly from
the photoaddition-cycloreversion sequence (Scheme 28). The photosubstrate
might be approached by directly coupling a version of 79 and 80, each of which
are accessable by efficient routes at this point.Alternatively, 69, the
photochemically unreactive diolide whose synthesis is outlined above, is only an
oxidation step away from 82.02R RO C
+
CO2H HO2C
79 80
69
81
Scheme 28
hv; A
43
Another strategy could employ coupling of half-reduced portions of each
component. Photometathesis of a substrate such as 85 could then lead to 86.
(Scheme 29).Again, cyclobutene 83 and cyclopentene 84 all compounds
available from chemistry already worked out in the course of this research.83
hv; A
84
(Ref. 21)
Scheme 29
1
44
85
Thus although an asymmetric synthesis of byssochlamic acid still remains
to be completed, valuable groundwork has been laid on which further efforts can
be built.45
CHAPTER 3
Experimental Section
Starting materials and reagents were obtained from commercialsources
and, unless otherwise stated, were used without further purification.Solvents
were dried by distillation from the appropriate drying agents immediately prior to
use. Tetrahydrofuran and ether were distilled from sodium and benzophenone
under an argon atmosphere. Diisopropylamine, triethylamine, acetonitrile and
dichioromethane were distilled from calcium hydride under argon.All solvents
used for routine isolation of products and chromatography were reagent grade.
Moisture and air sensitive reactions were carried out under an atmosphere of
argon. Reaction flasks were flame dried under a vacuum and then backfilled with
argon gas.Syringes needles were oven dried at 120 °C and cooled in a
desiccator over anhydrous calcium sulfate prior to use.
Unless otherwise stated, concentration under reduced pressure (or in
vacuo) refers to a rotary evaporator at water aspirator pressure.
Analytical thin layer chromatography (TLC) was performed using
precoated aluminum E. Merck TLC plates (0.2 mm layer thickness of silica gel 60
F-254). Compounds were visualized by ultraviolet light, and/or by heating the
plate after dipping in a solution of 14% ammonium molybdate tetrahydrate and
1.4% cerium(IV) sulfate in 1.6M sulfuric acid in water or a 1% solution of
potassium permanganate in 2% 1N sodium hydroxide in water.Flash
chromatography was carried out using E. Merck silica gel 60 (230-400 mesh
ASTM).
Melting points were measured using a Bilchi melting point apparatus, and
are uncorrected. Infrared (IR) spectra were recorded with a Nicolet 5DXB FT-IR46
spectrometer. Proton and carbon nuclear magnetic resonance (NMR) spectra
were obtained using either a Bruker AC-300 or a Bruker AM-400 spectrometer.
All chemical shifts are reported in parts per million (ppm) downfield from
tetramethylsilane using the 8 scale. 1H NMR spectral data are reported in the
order: chemical shift, number of protons, multiplicity (s=singlet, d=doublet,
t=triplet, q=quartet, m=multiplet and b=broad), and coupling constant (J) in Hertz
(Hz).
Chemical ionization (CI) high and low resolution mass spectroscopy
(HRMS and MS) were obtained using a Kratos MS-50 spectrometer with a
source temperature of 120 °C and methane gas as the ionizing source.
Perfluorokerosene was used as a reference. Electron impact (El) mass spectra
(HRMS and MS) were obtained using a Varian MAT311 or a Finnegan 4000
spectrometer.X-ray crystallographic data were collected on a Siemens P4
spectrometer and structures were solved using the direct methods program
contained in the SHELXTL (Silicon Graphics/Unix) software package.47
VMe02 02H
(R)-1-Methyl Hydrogen 4-Ethylcyclopentene-1,2-dicarboxylate (42).
To a rapidly stirred mixture of 34 (40.0 mg, 0.188 mmol) in 1 mL of acetone and 9
mL of pH 7 phosphate buffer (sodium phosphate, dibasic and potassium
phosphate dibasic) at room temperature was added porcine liver esterase (0.05
mL, 100 units) in ammonium sulfate buffer. The mixture was covered with a
balloon to prevent acetone evaporation. After being stirred at 30-35°C for 3.5 h,
the reaction mixture was acidified to pH 1-2 with 2M hydrochloric acid, then
immediately shaken with ethyl acetate (10 mL). The resulting emulsion was
treated with brine (2 mL) and filtered through Celite. The aqueous layer was
separated and was extracted with ethyl acetate (3 x 10 mL). The combined
organic layers were washed with brine, dried (anhydrous magnesium sulfate),
and concentrated in vacuo to yield 38 mg (100%) of 42: [a]p3 -7.8° (c 1.00,
CHCI3); IR (neat) 3400-2400 (br), 2955, 1722, 1682, 1650, 1444 cm-1; 1H NMR
(CDCI3, 300 MHz) 5 0.92 (3H, t, J = 7 Hz), 1.44 (2H, dq, J= 7 , 7 Hz), 2.20 (1H,
m), 2.60 (2H, m), 3.00 (2H, m), 3.90 (3H, s); 13C NMR (CDCI3, 75 MHz) 8 12.3,
28.6, 36.4, 41.5, 53.8, 137.8, 148.0, 163.8, 168.9; CIMS m/z 199 (M+1), 195,
181, 169, 167, 123, 109, 96; HRMS m/z 199.0969 (M+1) (calcd for C101-11504:
199.0971).Me02
48
N-(-1-Methylbenzy1)-2-(2-methoxycarboxyl-4-ethylcyclopent-1-enyl)
acetamide (44). To a solution of 42 (20.0 mg, 0.10 mmol) in dry acetone (0.5
mL) was added a solution of cyanuric chloride (9.2 mg, 0.05 mmol) in dry
acetone (0.5 mL) dropwise. The mixture was stirred at room temperature for 3.5
h and (S)-phenethylamine was added neat (12.1 mg, 0.10 mmol). The resulting
mixture was allowed to stir for 2 h at room temperature and filtered through
Celite. Solvent was removed on a rotary evaporator to leave an oil which was
chromatographed on silica, using 33% ethyl acetate in hexane as eluant, to yield
12.6 mg (42%) of 44:[oc]2,3 -13.6° (c 1.00, CHCI3); IR (neat) 3281, 3065, 3027,
2963, 2933, 1717, 1650, 1627, 1541, 1437, 1322 cm-1; 1H NMR (CDCI3) 8 0.90
(3H, t, J= 7 Hz), 1.43 (3H, m), 1.53 (3H, d, J = 7 Hz), 2.09 (1H, m), 2.51 (2H, m),
2.96 (2H, m), 3.76 (3H, s), 5.16 (1H, dq, J = 7,7 Hz), 7.35 (5H, m), 8.90 (1H, bs);
13C NMR (CDCI3) 8 12.5, 22.5, 28.6, 36.9, 41.9, 43.0, 49.3, 52.4, 126.5, 127.3,
128.8, 143.8, 149.2, 163.5, 167.2; MS m/z 302 (M+), 198, 181, 120, 105; HRMS
m/z 302.1755 (calcd for C18H2403N: 302.1756).49
N-(1-Methylbenzy1)-2-(2-hydroxycarboxyl-4-ethylcyclopent-1-eny1)-
acetamide(45).To a stirred solution of 44 (27 mg, 0.090 mmol) in dry
tetrahydrofuran (10 mL) was added a solution of lithium hydroxide monohydrate
(8.3 mg, 0.20 mmol) in water (5 mL).The mixture was stirred at room
temperature for 2 h, and most of the tetrahydrofuran was evaporated under
reduced pressure. The resulting mixture was washed with diethyl ether (2 x 1
mL) and acidified with 0.5M hydrochloric acid in water to a pH of ca. 2. The
mixture was extracted with ethyl acetate (3 x 5 mL), and the combined organic
layers were washed with brine, dried over anhydrous magnesium sulfate, and
filtered. Concentration under reduced pressure produced 27 mg (100%) of 45:
[a],233 +10.9° (c 1.00, CHCI3); 1H NMR (CDCI3) 50.90 (3H, m), 1.43 (2H, m), 1.60
(3H, d, J = 7 Hz), 2.22 (1H, m), 2..40-2.60 (2H, m), 2.80-3.10 (2H, m), 5.23 (1H,
dq, J = 7,7 Hz), 6.22 (1H, bs), 7.30-7.40 (5H, m).
yme02 02t-BLI
(+)-(S)-tert-Butyl Methyl 4-Ethylcyclopentene-1,2-dicarboxylate (46).
To a solution of 42 (561 mg, 2.83 mmol) and concentrated sulfuric acid (0.5 mL,
9 mmol) in distilled, dry dioxane (2.5 mL) at 10-15°C in a high-pressure tube
equipped with a stir-bar was added freshly-condensed isobutylene (15 mL, xs).50
The tube was immediately sealed and allowed to come to room temperature
while stirring, during which time the mixture became homogeneous. After 2.5 h,
the tube and contents were cooled to 100C, uncapped, and poured slowly into
iced, saturated sodium bicarbonate solution. The resulting mixture was extracted
with ether (3 x 25 mL), and organic extracts were combined and dried with
anhydrous magnesium sulfate, filtered, and concentrated under reduced
pressure.The resulting crude residue was purified by flash chromatography
using 10% ethyl acetate in hexanes to give 843 mg (89%) of the pure oil, 46:
.. [a]22p 10.40 (c 1.0, CHCI3); IR (neat) 2959, 2930, 2878, 2853, 1717, 1715, 1647,
1457, 1436, 1368, 1347, 1286, 1234, 1173, 1144 cm-1; 1H NMR (CDCI3) 8 0.90
(3H, t, J=7.3 Hz), 1.45 (2H, m), 1.49 (9H, s), 2.38 (3H, m), 2.84 (2H, m), 3.76
(3H, s); 13C NMR (CDCI3) 8 12.2, 27.9, 28.5, 38.4, 40.2, 40.3, 51.6, 81.5, 136.8,
140.8, 166.1; CIMS m/z 253 (M-), 199, 181, 167, 98, 93; HRMS mlz 199.0969
(M-C4H7) (calcd for C10H1504: 199.0970).
H02 02t-Bu
(+)-(S)-tert-Butyl Hydrogen 4-Ethylcyclopentene-1,2-dicarboxylate
(47). To a stirred solution of 46 (456 mg, 1.79 mmol) in freshly distilled, dry
tetrahydrofuran (25 mL) was added a solution of lithium hydroxide monohydrate
(130 mg, 3.10 mmol) in water (13 mL) dropwise. The resulting mixture was
allowed to stir for 30 min, and most of the tetrahydrofuran was evaporated under
reduced pressure and 5 mL water was added.The resulting solution was
washed with ethyl ether (2 x 3 mL) and acidified (0.5 M HCI) until cloudiness
persisted and maximized. The resulting mixture was extracted with ethyl ether (351
x 10 mL), organic portions combined, washed with brine, and dried over
anhydrous sodium sulfate. Solvent was evaporated under reduced pressure to
yield 420 mg (97%) of the essentially pure solid 47 as white crystals: mp 95-
980C; [a]22D +9.30 (c 1.0, CHCI3); IR (neat) 2961, 2930, 1726, 1700, 1635, 1454,
1435, 1369, 1345, 1300, 1252, 1156, 1090 cm-1; 1H NMR (CDCI3) 8 0.92 (3H, t, J
= 7 Hz), 1.43 (2H, dq, J . 7,7 Hz), 1.55 (9H, s), 2.13 (1H, m), 2.53 (2H, m), 3.02
(2H, m); 13C NMR (CDCI3) 8 12.1, 27.8, 28.3, 35.8, 41.8, 42.7, 85.3, 139.1,
147.8, 163.3, 167.9; CIMS m/z 185 (M-C4H7), 167, 141, 125, 95, 77; HRMS m/z
185.0813 (M-C4H7) (calcd for C9H1304: 185.0814).
CO2H
CO2Me
Methyl Maleate(50).To dry methanol (20 mL) was added maleic
anhydride (450 mg, 4.59 mmol). The mixture was stirred at room temperature for
10 min and concentrated under reduced pressure to yield 594 mg (100%) of 50:
1H NMR (CDCI3, 300 MHz) 8 3.90 (3H, s), 6.39 (1H, d, J = 12.6 Hz), 6.46 (1H, d,
J = 12.6 Hz); 13C NMR (CDCI3, 75 MHz) 8 51.0, 130.0, 131.4, 165.9, 166.1.
Br..CO2Me
NCO2H
1-Methyl 2-Bromomaleate (58). To bromomaleic anhydride (0.7206 g,
4.072 mmol) was added dry methanol (15 mL). The mixture was stirred at room
temperature for 10 min and concentrated under reduced pressure to yield 856
mg (100%) of 58:IR (neat) 3070, 3008, 2951, 2841, 1728, 1701, 16291431,52
1333, 1313, 1283, 1215, 1181 cm-1; 1H NMR (CDCI3, 400 MHz) 8 3.88 (3H, s),
6.51 (1H, s); 130 NMR (CDCI3, 100 MHz) 6 53.6, 125.8, 129.9, 164.0, 167.6;
CIMS m/z 193 (M-H20), 191, 179, 177, 131, 113.
1-Methyl Hydrogen 3-Propylcyclobutene-1,2-dicarboxylate (59). To a
rapidly stirred mixture of 30 (1.418 g, 6.68 mmol) in 30 mL of acetone and 300
mL pH 7 phosphate buffer (sodium phosphate, dibasic and potassium phosphate
dibasic) was added porcine liver esterase (1.00 mL, 2000 units) in ammonium
sulfate buffer.The mixture was covered with a balloon to prevent acetone
evaporationand stirred at 30-35°C for 3.5 h, acidified to pH 1-2 with 2M
hydrochloric acid, and immediately shaken with ethyl acetate (200 mL). The
resulting emulsion was treated with brine (50 mL) and flitered through Celite.
The aqueous layer was separated and was extracted with ethyl acetate (3 x 100
mL).The combined organic layers were washed with brine, dried over
anhydrous magnesium sulfate, and concentrated under reduced pressure to yield
1.271 g (100%) of 59: [a],2,3 0 (c 1.00, CHCI3); IR (neat) 3400-2800 (br), 2959,
2931, 1742, 1675, 1632, 1441, 1406 cm-1; 1H NMR (CDCI3, 400 MHz) 8 0.94
(3H, t, J = 7 Hz), 1.38 (3H, m), 1.88 (1H, m), 2.34 (1H, dd, J = 16, 5 Hz), 2.86
(1H, dd, J = 16, 2 Hz), 2.96 (1H, m), 3.92 (3H, s); 130 NMR (CDCI3, 75 MHz) 6
14.1, 20.6,33.9,34.2,39.9, 41.5, 53.4, 145.6, 149.6, 161.0, 165.4; CIMS m/z
199 (M+1),181,167,154, 137, 121, 111, 93, 79; HRMS m/z 199.0971 (M+1)
(calcd for C10H1504: 199.0971).53
Methyl 2- Hydroxymethyl- 3- propylcyclobutene Carboxylate (61). To a
solution of 59 (101 mg, 0.509 mmol) and triethylamine (52 mg, 0.514 mmol) in
dry, distilled tetrahydrofuran (0.75 mL) at -8°C was added a solution of ethyl
chloroformate (56 mg, 0.514 mmol) in tetrahydrofuran (0.125 mL) dropwise. The
mixture was allowed to stir for 35 min keeping the temperature between -8°C
and 0°C during which time a precipitate formed. The mixture was slowly filtered
into a stirred solution of sodium borohydride (38.7 mg, 1.02 mmol) in water (0.5
mL) at 10°C and allowed to stir for 30 min between 10°C and 18°C. 2M
hydrochloric acid in water was added until the mixture separated into two layers.
The layers were separated and the aqueous portion extracted with diethyl ether
(3 x 1 mL). Organic phases were combined and washed successively with 10%
sodium hydroxide in water, water, and brine.The solution was dried over
anhydrous sodium sulfate and solvent evaporated under reduced pressure to
give an oil which was chromatographed on silica, using 33% ethyl acetate in
hexane as eluant, to yield 78 mg (83%) of 61: IR (neat) 3414, 2955, 2922, 2876,
1713, 1655, 1438, 1339, 1307 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.92 (3H, t, J=
7 Hz), 1.32 (3H, m), 1.59 (1H, m), 1.84 (1H, m), 2.01 (1H, dd, J = 15, 1 Hz), 2.55
(1H, dd, J = 15, 4 Hz), 2.85 (1H, m), 3.76 (3H, s), 4.36 (2H, bs), 4.66 (1H, bs);
13C NMR (CDCI3, 75 MHz) 6 14.2, 21.0, 34.8, 35.4, 40.0, 52.2, 62.8, 134.2,
163.6, 165.0; CIMS m/z 185 (M-9, 167, 153, 107; HRMS m/z 185.1177 (calcd for
CB:M-1603: 185.1177).54
Methyl 2- tert- Butyldimethylsiloxymethyl -3- propylcyclobutene
Carboxylate (62). To a stirred solution of 61 (243 mg, 1.32 mmol) and 2,6-
lutidine (437 mg, 4.08 mmol) in dry, distilled dichloromethane (15 mL) at -78°C
was added tert-butyldimethylsilyl trifluoromethanesulfonate (0.910 mL, 3.96
mmol) dropwise. The mixture was allowed to gradually warm to 0°C while stirring
for 2 h. Methanol (4-5 mL) was added slowly and the mixture allowed to come to
room temperature. The reaction mixture was poured into 100 mL of water and
50 mL of dichloromethane. Phases were separated, and the organic portions
combined, washed with brine, and dried over anhydrous magnesium sulfate. The
solution was concentrated under reduced pressure and the residue purified by
chromatography on silica gel (10% ethyl acetate in hexanes as eluent) to yield
387 mg (100%) of 62: IR (neat) 2955, 2929, 2857, 1719, 1653, 1468, 1440 cm-1;
1H NMR (CDCI3, 300 MHz) 8 0.07 (6H, s), 0.90 (3H, t), 0.90 (9H, s), 1.34 (3H, m),
1.83 (1H, m), 2.06 (1H, dd, J=15, 4 Hz), 2.62 (1H, dd, J.15, 4 Hz), 2.81
m), 3.71 (3H, s), 4.50 (2H, s); 13C NMR (CDCI3, 75 MHz) 814.1, 20.5, 25.7,
(1H,
34.0,
34.9, 39.0, 50.7, 59.7, 132.8, 160.7, 163.1; MS m/z 299 (M+), 283,267,241;
HRMS m/z 299.2042 (calcd for C16H3103Si: 299.2042).OTBS
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2-Hydroxymethy1-1-tert-butyldimethylsiloxymethy1-4-propylcyclobut-
ene (63). To a stirred solution of diisobutyl aluminum hydride (0.15 mL, 1.0 M,
0.15 mmol) in hexanes at -78°C under argon was added a solution of 62 (15 mg,
0.051 mmol) in dry methylene chloride (0.05 mL) dropwise. After 3 h, the stirred
mixture was quenched with a mixture of methanol and methylene chloride (1:1,
0.25 mL) and allowed to come to room temperature. Methylene chloride (0.2 mL)
and 20% aqueous sodium potassium tartrate solution (Rochelle's Salt, 0.25 mL)
were added and the resulting mixture was stirred until the organic phase became
clear. Phases were separated, and the aqueous phase extracted with methylene
chloride (3 x 1 mL). The combined organic portions were dried over anhydrous
magnesium sulfate, and the solvent was evaporated to give 14.0 mg (100%) of
the pure oil, 63:IR (neat) 3437, 2954, 2928, 2856, 1464, 1387, 1362, 1255,
1068 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.12 (6H, s), 0.90 (3H, t, J=3.6 Hz), 0.93
(9H, s), 1.31 (4H, m), 1.83 (1H, dd, J=9.6, 0.2 Hz), 2.41 (1H, dd, J=10.1, 0.2 Hz),
2.60 (1H, m), 3.91 (1H, t, J=3.8), 4.07 (2H, d, J=3.8), 4.17 (2H, s); 13C NMR
(CDCI3, 75 MHz) 8 14.3, 20.9, 25.9, 32.9, 35.6, 39.9, 59.5, 61.9, 136.4, 144.9;
MS m/z 269 (M-1), 253, 213, 171, 139, 121, 109, 95, 93, 79, 75, 73; HRMS m/z
269.1937 (calcd for C15H2902Si: 269.1936).56
2-tert-Butyldimethylsiloxymethy1-3-propy1-1-cyclobutenylmethyl
Methyl 4-Ethylcyclopentene-1,2-dicarboxylate (64). To a solution of 63 (54
mg, 0.20 mmol) and 42 (40 mg, 0.20 mmol) in dry diethyl ether (1 mL) at room
temperature under argon was added consecutively asolutionof
dimethylaminopyridine (148 mg, 1.20 mmol) in 1:1 diethyl ethyl ether/chloroform
(4.0 mL), and a solution of dicyclohexylcarbodiimide (167 mg, 0.80 mmol) in 4:1
ether/chloroform (3.0 mL), dropwise.After 2.5 h, the solvent was evaporated
under reduced pressure and the residue macerated with cold acetone and
filtered through glass wool.The resulting solution was evaporated under
reduced pressure and the residue triturated 3-4 times with hexanes/ethyl acetate
(9:1). The hexane/ethyl acetate washes were combined and solvent evaporated
under reduced pressure to yield an oily solid mixture which was purified by flash
chromatography using 10% ethyl acetate in hexanes as eluant to give 77.0 mg
(86%) of the pure oil, 64: [at3 0° (c 1.00, CHCI3); IR (neat) 2954, 2928, 2854,
1723, 1461, 1437, 1261, 1223, 1148, 1089 cm-1; 1H NMR (CDCI3, 300 MHz) 8
0.06 (6H, s), 0.89 (3H, t, J = 7 Hz), 0.90 (9H, s), 0.91 (3H, t, J = 4 Hz), 1.31 (4H,
m), 1.46 (2H, dq, J = 7, 7 Hz), 1.93 (1H, dd, J = 12, 0.2 Hz), 2.33 (1H, m), 2.39
(2H, m), 2.46 (1H, dd, J = 12.0, 5 Hz), 2.58 (1H, m), 2.87 (2H, m), 3.75 (3H, s),
4.20 (2H, s), 4.71 (2H, s); 13C NMR (CDCI3, 75 MHz) ö 12.5, 14.5, 18.6, 21.0,
26.1, 28.8, 33.8, 35.1, 35.5, 38.8, 40.4, 40.6, 52.1, 59.9, 60.4, 138.7, 139.4,
143.6, 165.7; CIMS m/z 449 (M-1), 391, 297, 255, 181; HRMS m/z 449.2721
(calcd for C25H4105Si: 449.2723).57
2-Hydroxymethy1-3-propy1-1-cyclobutenylmethyl tort -Butyl4-
Ethylcyclopentene-1,2-dicarboxylate (67). To a solution of 47 (22.2 mg,
0.112 mmol) and 63 (30.0 mg, 0.112 mmol) in dry diethyl ether (0.6 mL) was
added sequentially solutions of 4-dimethyl-aminopyridine (86 mg, 0.70 mmol) in
ethyl ether/chloroform (1:1, 2.5 mL), and dicyclohexylcarbodiimide (92.5 mg,
0.448 mmol) in ethyl ether/chloroform (1:1, 2 mL). The mixture was left to stir at
room temperature under argon for 2.5 h, after which the solvent was evaporated
under reduced pressure. The resulting oily solids were macerated with cold
acetone and filtered through glass wool, and the supernatant evaporated under
reduced pressure to yield an oil which was purified by flash chromatograpy using
7% ethyl acetate in hexanes. To this neat oil was added a solution of
tetrabutylammonium fluoride (0.15 mL, 1.0 M in tetrahydrofuran), and the mixture
allowed to stir for 30 minutes.The mixture was quenched with saturated
aqueous ammonium chloride (0.20 mL) and allowed to stir further 10 min. Most
of the solvent was evaporated under reduced pressure and to the resulting
product was added water (0.5 mL) and diethyl ether (0.5 mL). The layers were
separated and the aqueous layer extracted further with diethyl ether (3 x 1 mL).
Organic phases were combined, washed with brine, dried over anhydrous
sodium sulfate, and evaporated under reduced pressure to yield a crude material
which was purified by flash chromatography using 33% ethyl acetate in hexanes
to give 30 mg (72%, 2 steps) of the pure oil, 67: [43 0° (c 1.00, CHCI3); IR
(neat) 3600-3300 (br) ,2958, 2926, 2873, 1713, 1646, 1457, 1367, 1342, 1282,
1229, 1173, 1148, 1092 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.90 (6H, t, J=7.258
Hz), 1.38 (6H, m), 1.49 (9H, s), 1.59 (1H, m), 1.92 (1H, dd, J=13.2, 1 Hz), 2.33
(3H, m), 2.64 (1H, m), 2.85 (2H, m), 4.17 (2H, d, J=5.7 Hz), 4.66 (1H, d, J=13
Hz), 4.76 (1H, d, J=13 Hz); 13C NMR (CDCI3, 75 MHz) 5 12.2, 14.2, 20.6, 27.9,
28.5, 33.5, 35.2, 38.4, 40.0, 40.1, 40.5, 59.6, 60.7, 81.7, 136.4, 138.4, 141.8,
144.5, 165.0, 165.8; CIMS mtz 377 (M-1), 361, 321, 305, 185, 167, 139, 121,
109; HRMS m/z 377.2330 (calcd for C22H3305: 377.2328).
2-Hydroxymethy1-3-propy1-1-cyclobutenylmethyl Hydrogen 4-
Ethylcyclopentene-1,2-dicarboxylate (68). To a solution of 67 (5.0 mg, 0.013
mmol) in dry dichloromethane (0.15 mL) under argon was added a solution of 10
c/0 trifluoroacetic acid in dichloromethane (0.1 mL). The mixture was allowed to
stir for 30 min at room temperature, after which the solvent was evaporated
under reduced pressure to yield 4 mg (100%) of the oil,68:[a]p' 0° (c 1.00,
CHCI3); IR (neat) 3600-2500 (br) ,2959, 2927, 2873, 1785, 1722, 1640, 1455,
1376, 1282, 1217, 1167, 1089 cm-1; 1H NMR (CDCI3, 300 MHz) 5 0.92 (6H, t, J=
7.2 Hz), 1.33 (3H, m), 1.44 (4H, m), 1.64 (1H, m), 1.99 (1H, d, J = 13.6 Hz), 2.19
(1H, m), 2.63 (4H, m), 3.05 (2H, m), 4.24 (1H, s), 4.85 (1H, d, J = 20 Hz), 4.87
(1H, s); 130 NMR (CDCI3, 75 MHz) 6 12.0, 14.1, 20.6, 28.3, 33.5, 35.2, 36.0,
40.3, 41.3,42.7,60.3,61.6, 137.2,137.5,143.0, 145.3, 168.3, 179.1.; CIMS trilz
280 (M-42),252,221,140, 109, 83,71, 69.0
0
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Diolide (69). To a stirred solution of 2,4,6-trichlorobenzoyl chloride (80.0
mg, 0.328 mmol) and triethylamine (38.0 mg, 0.376 mmol) in dry, distilled,
tetrahydrofuran (2.0 mL) was added a solution of 68 (100 mg, 0.310 mmol) in
tetrahydrofuran (2.0 mL). The mixture was allowed to stir at room temperature
overnight and filtered through glass wool into dry toluene (20 mL). The resulting
solution was added dropwise via syringe pump over 6.5 h to a refluxing solution
of 4-dimethylaminopyridine (98.0 mg, 0.802 mmol) in toluene (15 mL). The
mixture was allowed to stir at reflux for 3 h, after which the heat was removed
and stirring continued overnight at room temperature. The reaction mixture was
filtered through a pad of silica, and the solvent evaporated under reduced
pressure. The resulting crude substance was purified by flash chromatography
using 10% ethyl acetate in hexanes as eluant to yield 41 mg (44%) of the pure
oil, 69:[oa]p3 0° (c 1.00, CHCI3); IR (neat) 2956, 2925, 2872, 1723, 1634, 1455,
1381, 1284, 1104 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.92 (6H,m), 1.29 (4H, m),
1.48 (3H, m), 1.94 (1H, dq, J=7.1, 7.1 Hz), 2.40 (4H, m), 2.64 (1H, m), 2.89 (2H,
m), 4.74 (4H, m); 13C NMR (CDCI3, 75 MHz) 814.1, 20.7, 22.6, 28.5, 33.9, 35.2,
38.8,39.0,39.1,40.7, 59.7, 60.8, 134.3, 140.2, 141.0, 141.3, 175.3. CI MS miz
305(M+),303,287, 261, 213, 195, 185, 167, 139, 121, 109, 69; HRMS m/z
305.1753 (calcd for C18H2504: 305.1753).60 C Me02 0 H
()-(R)-Methyl 4- Ethyl -2- hydroxymethylcyclopentene Carboxylate
(71). To a cooled, stirred solution of triethylamine (0.737 mL, 5.29 mmol) and 42
(1.048 g, 5.289 mol) in dry, distilled tetrahydrofuran (7.5 mL) at -5°C was added a
solution of ethyl chloroformate (0.506 mL, 5.29 mmol) in tetrahydrofuran (2.0 mL)
dropwise. The mixture was stirred at -5°C for 30 min and filtered directly into a
stirred, cooled solution of sodium borohydride (400.0 mg, 10.58 mmol) in water
(5 mL) at 0°C. The mixture allowed to stir for 30 min and acidified to pH = 7 with
2M hydrochloric acid in water. Most of the tetrahydrofuran was evaporated under
reduced pressure and the resulting mixture poured into diethyl ether (10 mL) and
water (10 mL). Layers were separated, and the aqueous layer extracted with
diethyl ether (3 x 10 mL). Organic portions were combined, washed successively
with 10% sodium hydroxide in water, water, and brine, and dried over anhydrous
magnesium sulfate. Evaporation of solvent under reduced pressure produced a
residue which was purified by chromatography on silica gel, using 33% ethyl
acetate in hexanes as eluent, to yield 0.872 g (90%) of 71: [a]2,3 -5.7° (c 1.0,
CHCI3); IR (neat) 3418 (br), 2955, 2924, 2875, 2851, 1708, 1640, 1436, 1322,
1247, 1191, 1118, 1008, 767 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.89 (3H, t, J =
7 Hz), 1.40 (2H, dq, J = 7, 7 Hz), 2.16 (1H, m), 2.28 (2H, m), 2.74 (2H, m), 3.74
(3H, s), 4.00 (1H, t, J = 6 Hz), 4.40 (2H, d, J = 4 Hz); 13C NMR (CDCI3, 75 MHz)
8 12.2, 28.7, 37.6, 39.5, 43.0, 51.6, 60.5, 127.7, 159.4, 167.2; CIMS m/z 184 (M),
167, 153, 135, 123, 107, 95, 81; HRMS m/z 185.1177 (calcd for C10H1703:
185.1177).61
me02 oTBS
(+)-(R)-Methyl4-Ethyl -2-tert-butylsiloxymethylcyclopentene
Carboxylate (72). To a cooled, stirred solution of 71 (13 mg, 0.070 mmol) and
2,6-lutidine (46 mg, 0.42 mmol) in dry, distilled dichloromethane (1.0 mL) at 0°C
was added tert-butyldimethylsilyl trifluoromethanesulfonate (58 mg, 0.22 mmol)
dropwise. The mixture was stirred at 0°C for 1.5 h. Methanol (1 mL) was added
dropwise and the reaction mixture allowed to warm to room temperature and stir
an additional 15 min. The mixture was poured into dichloromethane (10 mL) and
3% copper sulfate in water (10 mL) and phases separated. The aqueous portion
was extracted with dichloromethane (3 x 10 mL) and the combined organic layers
were washed with brine, dried over anhydrous magnesium sulfate, filtered and
concentrated under reduced pressureThe residue was purified by
chromatography on silica gel, using 6% ethyl acetate in hexanes as eluent, to
yield 20 mg (95%) of 72: [a]2,3 +1.6° (c 1, CHCI3); IR (neat) 2954, 2929, 2855,
1713, 1644, 1464, 1435, 1361, 1233, 1191, 1122, 1086, 1034, 840 cm-1; 1H NMR
(CDCI3, 300 MHz) 8 0.06 (6H, s), 0.90 (3H, t, J = 6 Hz), 0.91 (9H, s), 1.41 (2H,
dq, J = 6, 6 Hz), 2.19 (1H, m), 2.28 (2H, m), 2.81 (2H, m), 3.70 (3H, s), 4.70 (2H,
s); 13C NMR (CDCI3, 75 MHz) 8 -5.5, 12.3, 18.2, 25.8, 28.8, 37.3, 39.4, 41.2,
50.9, 61.0, 125.3, 159.5, 166.0; CIMS miz 299 (M+), 283, 267, 251, 241, 167,
135, 115, 107, 89, 75; HRMS m/z 299.2041 (calcd for Ci6H3103Si: 299.2042).62
OyH OTBS
(+)-(S)-1-tert-Butyldimethylsiloxymethy1-2-hydroxymethy1-4-ethyl-
cyclopentene (73). To a cooled, stirred solution of diisobutylaluminum hydride
(5.0 mL, 1.0M, 5.0 mmol) in hexanes at -78°C was added a solution of 72 (500.0
mg, 1.675 mmol) in dry, distilled dichloromethane (4.0 mL) dropwise.The
mixture was stirred at -78°C for 3 h. Methanol (5 mL) was added and the mixture
allowed to warm to room temperature.Dichloromethane (8 mL) and 20%
Rochelle's Salt in water (8 mL, sodium potassium tartrate) were added and the
mixture allowed to stir until both layers were transparent.Phases were
separated, and the aqueous portion extracted with dichloromethane (4 x 10 mL).
The combined organic layers were washed with brine, dried over anhydrous
magnesium sulfate, filtered and concentrated under reduced pressure The
residue was purified by chromatography on silica gel, using 20% ethyl acetate in
hexanes as eluent, to yield 360 mg (80%) of 73: [oct3 +1.0° (c 1.0, CHCI3); IR
(neat) 3349 (br), 2955, 2927, 2855, 1465, 1253, 1082, 1006, 776 cm-1; 1H NMR
(CDCI3, 300 MHz) 8 0.09 (6H, s), 0.89 (3H, t, J = 7 Hz), 0.91 (9H, s), 1.40 (2H,
dq, J = 7 Hz, 7Hz), 2.09 (3H, m), 2.55 (2H, m), 4.16 (2H, s), 4.23 (2H, s); 13C
NMR (CDCI3, 75 MHz) 8 -5.5, 12.4, 18.3, 25.8, 29.1, 37.8, 41.2, 41.4, 59.6, 60.5,
136.3, 136.3.63
2-tert-Butyl Methyl 3-Propylcyclobutene-1,2-dicarboxylate (74). To a
solution of 59 (269 mg, 1.36 mmol) and concentrated sulfuric acid (0.20 mL, 3.6
mmol) in distilled, dry dioxane (5.0 mL) at 10-15°C in a high-pressure tube
equipped with a stir-bar was added freshly-condensed isobutylene (10 mL, xs).
The tube was immediately sealed and allowed to come to room temperature
while stirring, during which time the mixture became homogeneous. After 7.5 h,
the tube and contents were cooled to 100C, uncapped, and poured slowly into
iced, saturated sodium bicarbonate solution. The resulting mixture was extracted
with ether (3 x 25 mL), and organic extracts were combined and dried with
anhydrous magnesium sulfate, flitered, and concentrated under reduced
pressure.The resulting crude residue was purified by flash chromatography
using 10% ethyl acetate in hexanes to give 242 mg (70%) of the pure oil, 74; IR
(neat) 2958, 2928, 1710, 1636, 1368, 1329, 1298, 1257, 1169, 1133 cm-1; 1H
NMR (CDCI3, 300 MHz) 6 0.92 (3H, t, J = 7 Hz), 1.36 (3H, m), 1.50 (9H, s), 1.80
(1H, m), 2.72 (1H, dd, J = 15, 4 Hz), 2.20 (1H, dd, J = 15, 2 Hz), 2.89 (1H, m),
3.77 (3H, s); 13C NMR (CDCI3, 75 MHz) 5 14.0, 20.4, 27.9, 33.4, 34.1, 39.9,
51.4, 81.4, 142.5, 144.7, 161.0, 162.1; CIMS m'z 227 (M-27), 199 (M-C4H8), 195,
181, 167, 151, 121, 111, 93.64
2-tert-Butyl Hydrogen 3-Propylcyclobutene-1,2-dicarboxylate(75).
To a stirred solution of 74 (402 mg, 1.58 mmol) in freshly distilled, dry
tetrahydrofuran (22 mL) was added a solution of lithium hydroxide monohydrate
(120 mg, 2.86 mmol) in water (11 mL) dropwise. The resulting mixture was
allowed to stir for 4 h.Most of the tetrahydrofuran was evaporated under
reduced pressure and 5 mL water was added.The resulting solution was
washed with ethyl ether (2 x 3 mL) and acidified (0.5 M HCI) until cloudiness
persisted and maximized. The resulting mixture was extracted with ethyl ether (3
x 10 mL), organic portions combined, washed with brine, and dried over
anhydrous sodium sulfate. Solvent was evaporated under reduced pressure to
yield 335 mg (88%) of the pure oil 75:IR (neat) 3500-2500 (br), 3158, 3063,
2961, 2931, 2870, 2768, 2687, 1742, 1662, 1627, 1458, 1414, 1370, 1342, 1296,
1152, 1109, 837 cm-1; 1H NMR (CDCI3, 400 MHz) 8 0.92 (3H, t, J = 5 Hz), 1.38
(3H, m), 1.55 (9H, s), 2.01 (1H, m), 2.23 (1H, dd, J = 12, 1 Hz), 2.75 (1H, dd, J.
12, 3 Hz), 2.97 (1H, m); 13C NMR (CDCI3, 75 MHz) 5 13.9, 20.3, 27.8, 33.0, 33.4,
40.6, 85.0, 142.7, 153.1, 160.5, 164.4; CIMS rniz 241 (M+), 228, 213, 195, 185,
167, 154, 141, 95, 69; HRMS tri/z 241.1441 (calcd for C13H2004: 241.1440).65
2-tert-Butyldimethylsiloxymethy1-4-ethyl -1-cyclopentenylmethyl 2-
ter[ -Butyl 3-Propylcyclobutene-1,2-dicarboxylate(76) To a solution of 73
(155 mg, 0.573 mmol) and 75 (138 mg, 0.574 mmol) in dry, distilled
dichloromethane (3.0 mL) was added sequentially solutions of 4-dimethyl-
aminopyridine (140 mg, 1.15 mmol) in dichloromethane (1.5 mL) and 1-(3-
dimethylaminopropy1)-3-ethylcarbodiimide hydrochloride (EDCI) (123 mg, 0.689
mmol) in dichloromethane (4.0 mL) at room temperature. The mixture was left to
stir at room temperature under argon for 6 h, after which the solvent was
evaporated under reduced pressure. The resulting oily solid was purified by flash
chromatograpy using 20% ethyl acetate in hexanes to give 195 mg (76%) of 76
as an oil:IR (neat) 2956, 2928, 2855, 1711, 1638, 1463, 1369, 1291, 1254,
1206, 1171, 1131, 1088, 1061, 840, 777 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.05
(6H, s), 0.89 (15H, m), 1.37 (5H, m), 1.49 (9H, s), 1.79 (1H, m), 2.12 (3H, m),
2.19 (1H, dd, J = 15, 2 Hz), 2.58 (2H, m), 2.72 (1H, dd, J . 15, 5 Hz), 2.92 (1H,
m), 4.24 (2H, s), 4.76 (2H, s); 13C NMR (CDCI3, 75 MHz) 8 -5.4, 12.4, 14.0, 18.3,
20.4, 25.8, 27.9, 28.0, 29.1, 33.4, 34.1, 37.7, 37.7, 40.0, 40.5, 40.9, 59.7, 60.5,
81.4, 130.5, 140.6, 142.5, 144.8, 161.0, 161.5; CIMS m/z 491 (M-), 435, 379,
299, 283, 253, 241, 197, 185, 167, 139, 121, 95, 75; HRMS m/z 491.3185 (calcd
for C28H48O5Si: 491.3193).66
2-Hydroxymethy1-4-ethyl-1-cyclopentenylmethyl 2-tert-Butyl 3-
Propylcyclobutene-1,2-dicarboxylate (77). To a stirred solution of 76 (47 mg,
0.10 mmol) in dry, distilled tetrahydrofuran (1 mL) was added a solution of
tetrabutylammonium fluoride (1.0 mL, 1M, 1.0 mmol) in tetrahydrofuran. The
mixture was stirred at room temperature for 30 min. A saturated solution of
ammonium chloride in water (1 mL) was added and the mixture was allowed to
stir for 10 min.Most of the tetrahydrofuran was evaporated under reduced
pressure. Diethyl ether (1 mL) and water (1 mL) were added, phases separated,
and the aqueous layer extracted with diethyl ether (3 x 1 mL). The combined
organic layers were washed with brine, dried over anhydrous sodium sulfate,
filtered and concentrated under reduced pressure. The residue was purified by
chromatography on silica gel, using 33% ethyl acetate in hexanes as eluent), to
yield 22 mg (58%) of 77 as a mixture of diastereomers:IR (neat) 3486 (br),
2958, 2925, 2872, 1709, 1636, 1458, 1369, 1293, 1255, 1208, 1169, 1132, 1060
cm-1; 1H NMR (CDCI3, 300 MHz) 6 0.87 (6H, m), 1.34 (5H, m), 1.45 (9H, s), 1.76
(1H, m), 2.14 (4H, m), 2.59 (3H, m), 2.68 (1H, dd, J=15, 4 Hz), 2.86 (1H, m),
4.18 (2H, s); 13C NMR (CDCI3, 75 MHz) 6 12.3,14.0,20.3,27.6,27.9,27.9,
29.0, 33.5, 34.0, 37.8, 37.8,39.9, 40.0, 40.5, 40.7,41.0,41.0,59.0,60.6,81.5,
131.5, 141.2, 142.9, 144.7,161.0, 161.7, 161.7; CIMS miz 377 (M-1), 361,321,
305, 213, 195, 185, 167, 139, 121; HRMS m/z 379.2484 (calcd for C22H3505:
379.2485).67
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PART TWO: AN APPROACH TO THE CORE RING SYSTEM OF
CP-225,917
Chapter 4
History and Background
Heart disease and cancer, respectively, are the two most common causes
of death in the United States in this latter half of the twentieth century.33 In 1995,
over 700,000 people in the United States died from heart disease and over
500,000 died of cancer.Considerable effort in the area of health-related
research continues to be devoted to controlling these diseases.
One of the leading contributors to coronary heart disease and coronary
artery disease is atherosclerosis. Atherosclerosis is a process in which cellular
debris composed of cholesterol esters, lipids, and other materials form plaques
on the inside walls of medium and large arteries. The artery walls subsequently
harden and the cross-sectional area of the lumen is reduced, resulting in lower
blood flow. High serum cholesterol levels have been established as an important
risk factor for atherosclerosis, and cholesterol lowering regimens have been
shown to decrease the incidence of coronary heart disease?'
One method of reducing serum cholesterol levels involves the inhibition of
enzymes along the biosynthetic pathway to cholesterol. For example, the Merck
drug mevinolin (87),35 from Aspergillus terreus, has shown potent inhibitory
activity toward 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA
reductase). This is a major regulatory enzyme in the cholesterol biosynthetic
pathway, and its inhibition has proven successful in lowering serum cholesterol
levels in man.3771
87: Mevinolin
Another important enzyme in the biosynthesis of cholesterol, squalene
synthase, has also been targeted for inhibition. Squalene synthase is bound to
membranes of the endoplasmic reticulum and catalyzes the formation of
presqualene pyrophosphate from two units of farnesyl pyrophosphate (Figure
4.1).This transformation represents the first committed step in cholesterol
biosynthesis from farnesyl pyrophosphate,38 and inhibition of squalene synthase
would therefore provide a means for interrupting in vivo cholesterol production.
00
II II
"0-P-0-P-0
6-6-farnesyl pyrophosphate
o0
II II
0-P-O-P-0-
farnesyl pyrophosphate6-6-
91 91 0-P-O-P-0.
6-6-
presqualene pyrophosphate
squalene
synthase
Figure 4.1: Biosynthesis of Presqualene Pyrophosphate72
Also, such an inhibitor would control the level of serum cholesterol without
affecting the production of nonsteroidal compounds derived from farnesyl
pyrophosphate.3'
Early attempts to identify novel, potent, and selective inhibitors of
mammalian squalene synthase concentrated on the synthesis of substrate and
transition state analogues of the enzymatic reaction.Farnesyl pyrophosphate
analogues were studied by De Monte Ilane and by Biller,41 who utilized a series
of isoprenoid phosphates toinhibit squalene synthases at micromolar
concentrations. Presqualene phosphonophosphates,' ammonium analogues of
presqualene pyrophosphate,43 prenyl-substituted cyclobutanones,44 and a series
of amphiphilic polyisoprenoid compounds45 were also investigated to this end, but
demonstrated only modest activities.
In the early 1990's several research teams simultaneously and
independently reported the isolation of a naturally occurring class of compounds
which were found to inhibit squalene synthase at nanomolar concentrations. The
group at Merck referred to them as zaragozic acids,46 while groups at Glaxo' and
Tokyo Noko University/Mitsubishi48 called them squalestatins.While all three
research groups isolated zaragozic acid A (squalestatin I, 88), the organisms
which produced these compounds in the three laboratories were different. Merck
isolated 88 from an uncharacterized sterile fungus ATCC 20986 found in a
riverbed in the province of Zaragoza, Spain. Glaxo isolated 88 from a different
fungus, CP2932, found in a soil sample from Portugal, while the Japanese group
extracted it from yet another fungus, Setosphaeria khartoumensis. Merck has
since noted that no fewer than eleven different taxa of fungi (of the genus
Ascomycotina) produce zaragozic acids.'73
es
The structures of the zaragozic acids all possess the same 2,8-
dioxabicyclo[3.2.1]octane core, but vary in the composition of their sidechains.
These compounds have since become popular synthetic targets' due to their
potent bioactivities and their unique, highly functionalized structures.
During a subsequent screening for other potential inhibitors of squalene
synthase, two compounds named CP-225,917 (8) and CP-263,114 (9) were
discovered by a research group at Pfizer in the culture broth of an unidentified
fungus.51The anhydrides 8 and 9 were both active in squalene synthase
inhibition assays, displaying IC50 values of 43 1.1,M and acting as reversible,
noncompetitive inhibitors.
8
The producing organism was collected from a juniper twig in Texas and
appears to have characteristics of a sterile Phoma species. Although this fungus
has not yet yielded to taxonomic classification, zaragozic acid A (88) was also74
found in its fermentation broth.The organism has been deposited at the
American Type Culture Collection under accession number ATCC 74256.
Structurally, 8 and 9 are unique in that they contain strained tetra- and
pentacyclic cores with a bridgehead double bond; they represent the most
complex nonadrides isolated to date. According to Bredt's rule and it's revision,
the bridgehead double bond contained in the bicyclo[4.3.1]cleca-1,6-diene
system should be stable at room temperature.The parent system,
bicyclo[4.3.1]cleca-1-ene-10-one has been synthesized' and was indeed shown
to be stable at room temperature.
Ras farnesyl transferase, or farnesyl-protein transferase, is another
enzyme which utilizes farnesyl pyrophosphate as a substrate' This enzyme
catalyzes the addition of a farnesyl group to a cysteine residue at the carboxy
terminus of the protein p21. The latter is the product of the ras oncogene. This
transformation is a necessary step for the membrane localization of the protein,
where it acts as a molecular switch for cell growth. A one-amino acid mutation of
p21 renders it permanently activated, so that it pushes regulation of cell growth
and division out of control, resulting in certain types of cancer.It has been
postulated that inhibition of ras farnesylation could be an effective approach to
controlling such abnormal cell growth.55
In this regard, compounds 8 and 9 were also found to inhibit ras farnesyl
transferase from rat brain with IC50 values of 6 and 20 [LM,respectively.
Based on published work on the biosynthesis of other nonadrides such as
glauconic acid (vide infra) and the rubratoxins, the biosynthesis of 8 and 9 can
be postulated as in Figure 4.2, where head-to-head condensation of two 16-
carbon subunits gives intermediate 90. These units, in turn, can arise from lauric
acid (or another 12-carbon acid) and oxaloacetic acid.The 16-carbon unit75
HO2C
8
lauric acid
+
/
HO2CCO2H
oxaloacetic acid
HO2C
89
7
HOH2851-
CO2H
0 H
H 02C .,,,,P -1,-L,
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Figure 4.2: Proposed Biosynthesis of CP-225, 917 and CP-263,114
decylcitric acid, 91, is a known fungal metabolite 5. A decarboxylative loss of
one carbon from 89 gives a total carbon count of 31, as in 8.
91
Citric acid derivatives with a long ara-alkyl chain corresponding to the
zaragozic acid A backbone have been reported as minor components of
fermentation broths which produce zaragozic acids.53 These units can be derived
from the condensation of oxaloacetic acid with the corresponding 19- and 21-
carbon monocarboxylic acids.5' This presents the possibility that condensation of
oxaloacetic acid with long-chain monocarboxylic acids may be a common
biosynthetic pathway for both nonadrides and zaragozic acids.5176
Synthetic entries into the bicyclo[4.3.1]dec-1-ene system of 8 and 9 have
been vigorously pursued by several groups.In this regard, Cordiner, et a1.53
noted that sulfuric acid dehydration of 92' produced 93 in good yield (Scheme
30) while pyrolysis of benzoate 94 gave a 1:2 mixture of 93 and 95 in 70% yield.
0 0
11 11 H 2SO4
OH
92
94
A
(70%)
93
93
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A more comprehensive route to the core ring system of CP-225,917 has
been taken by the Nicolaou group who generated two different approaches to the
central framework of 8 and 9. The first approach' uses an intramolecular Diels-
Alder reaction to create the bicycle. Beginning with 1,4-butanediol (Scheme 31),
monoprotection of the derived alkoxide with tert-butyldimethylsilyl chloride gave
the silyl ether 96 which was oxidized under modified Swern conditions' to the
aldehyde 97. Transformation to the imine 98 was accomplished by reaction with
cyclohexylamine in benzene.H H
TBSCI, NaH
THE
(90%)
TBSO
0 H
96
77
S03pyridine, DMSO,
Et3N
TBSCCHO cyclohexylamine TBS
N
97 benzene 96
Scheme 31
CH2Cl2
(80%)
The imine 98 was then deprotonated with lithium diisopropylamide in
tetrahydrofuran (Scheme 32) and alkylated with allyl bromide to provide aldehyde
TBSN
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99. Subsequent reduction of 99 with sodium borohydride in methanol furnished
the alcohol 100 in 58% yield from 97. The free alcohol was protected as its
benzyl ether 101, and the olefin was ozonized with a reductive workup to give
aldehyde 102. At this point, another cyclohexylamine Knoevenagel alkylation
was employed which, after reaction with n-butanal and subsequent dehydration,
provided aldehyde 104 as a mixture of E- and Z- isomers in 74% yield.
The diene required for the Diels -Alder reaction was set in place by
deprotonation of 104 with potassium hydride followed by O- methylation of the
CHO
TBSO-.OBn
104
a) KH / DME
b) Me2SO4 / HMPA
TBSO
(96%)
OBn
105
a) LHM
CN
108
b) TBAF/THF /H20 (95:5)
(86%)
110
Scheme 33
Me2AICI
CH2Cl2
-10°C
(86%)79
resultingenolatewithdimethylsulfateinthepresenceof
hexamethylphosphoramide to give 105 (Scheme 33). Insertion of the dienophile
began by deprotection of the silyl ether with tetra-n-butylammonium fluoride and
transformation of the free alcohol 106 into primary iodide 107.Lithium
hexamethyldisilazide was used to generate the enolate of nitrile 108, which was
alkylated with iodide 107 and desilylated in situ to furnish the substrate 109 for
intramolecular Diels -Alder reaction.This strategy was shown to be a viable
approach to the core of CP-225,917 as 110 was produced in 86% yield in the
presence of the Lewis acid dimethylaluminum chloride.
The approach of Nicolaou is promising in that the two alkyl chains of 110
are positioned correctly for the natural product. Asymmetric alkylation could be
used, in principle, to set the stereocenter adjacent to the bridgehead double bond
PMB
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Figure 4.3: Nicolaou Approach to Core of CP-225,91780
as well. However, in the natural products 8 and 9 this stereocenter is quaternary.
It remains to be seen whether this center can be set in a stereocontrolled fashion
and what effect a quaternary center at this position might have on the key
cycloaddition reaction.
Later the same year, the Nicolaou laboratory published another
approach to the bicyclo[4.3.1]dec-1-ene core which addressed the quaternary
center issue mentioned above. This second, more complex strategy is based on
the intramolecular trapping of a rhodium-generated carbenoid species,' followed
by divinylcyclopropane rearrangements and radical cyclization to give 111
(Figure 4.3). The Nicolaou paper appeared after the publication of a similar
approach by Davies66 which was unsuccessful, but promising.
As seen in Scheme 34, synthesis of the carbene precursor began by using
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a modified Taber procedure.67 Methyl ester 112 was treated with 2.5equivalents
of potassium hexamethyldisilazide, followed by addition of methyl benzoate, to
generate phenyl ketone 113. Diazo transfer was then accomplished by reaction
with 4-nitrobenzenesulfonyl azide and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU)
and provided diazo ester 114 in excellent yield.The subsequent carbenoid
cyclopropanation proved to be successful, giving the bicyclo[3.1.0]hexane 115 in
87% yield after treatment with 3 mol % of dirhodium tetraacetate.The
configuration of the oxidized chiral carbon in 115, however, was opposite to that
deemed necessary for the pending 5- exo-SH2' cyclization.68A subsequent
Mitsunobu inversions was therefore required, ultimately providing the epimer of
115 (see compound 116, Scheme 35).
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After converting the methyl ester of 115 to methyl ketone 116 using
Grignard chemistry, silyl enol ether 117 was prepared by trapping the potassium
enolate at -78°C with triethylsilyl chloride (Scheme 35). A divinylcyclopropane
rearrangement was then carried out by allowing 117 to warm to 45°C, giving the
bicyclo[4.3.1]deca-1,5-diene 118. Tetra-n-butylammonium fluoride treatment of
118 produced ketone 119 in 95% yield over two steps. A modified Mitsunobu-
type reaction71 attached the thiophenyl functionality to the molecule to yield 120,
which was deprotected with dichlorodicyanoquinone to furnish alcohol 121.
The substrate 122 for radical cyclization was formed by esterification of
121 with cc-bromoacetic acid (Scheme 36) in the presence of dicyclohexyl-
carbodiimide and 4-(dimethylamino)pyridine. The crucial radical cyclization was
realized by irradiation of 122 in benzene in the presence of hexamethylditin and
gave 111 in 61% yield.
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The above synthesis employs novel chemistry and combines three
powerful synthetic operations in a single sequence.Its weaknesses are that it83
requires superfluous inversion of stereogenic centers and almost 30 synthetic
steps to reach a relatively simple model for CP-225,917. Additionally, the final
radical reaction, although elegant, leads to the incorrect stereochemical
configuration at the quaternary center for the targeted natural products.
An approach which addresses not only the core framework but also most
of the required functionality in 8 and 9 was subsequently developed by Clive.72
His strategy envisions an anionic oxy-Cope rearrangemenf3 to access the
bicyclo[4.3.1]dec-1-ene core, and includes provisions for the quaternary center
and, to a lesser degree, the alkyl chains (Figure 4.4).
anionic oxy-Cope
rearrangement
0 OR5
R2
R4
R50
0 R1
Fig. 4.4: Clive Approach to Core of CP-225,917
Clive's synthesis begins by elaboration of a norbornene (Scheme 37).
Dimethyl ketal 12374 is saturated using a palladium catalyst, then protected as the
benzoyl ester by treatment with benzoyl chloride and pyridine to give norbornane
124.This esterification was necessary to prevent decomposition during
subsequent deketalization, which was accomplished in aqueous acetic acid.
Reaction of the resulting ketone with vinylmagnesium bromide in diethyl ether,
followed by saponification of the benzoyl ester with lithium hydroxide gave the
diol 125 in 53% yield over 3 steps, along with a small amount of the vinyl
diastereomer. Dess-Martin oxidation75 led to the ketone 126, and protection of
the alcohol with triethylsilyl trifluoromethanesulfonate yielded 127. This latter
step was necessary in order to guard against retro-aldol fragmentation. Aldol84
condensation of 127 with acetaldehyde, using lithium diisopropylamide as the
base, gave alcohol 128 as a mixture of diastereomers. Treatment with methane-
OH
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129
sulfonyl chloride and triethylamine, followed by elimination with1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) provided the E-alkene 129 in 60% yield,
along with the separable Z-alkene in 11% yield.
Luche reduction' of 129 was nonstereoselective (Scheme 38) and gave
alcohols 130 as a 1:1 mixture of epimers in 86% yield.After separation of the
two diastereomers, each alcohol was taken on separately with similar yields for
the final three steps.Protection of 130 as benzyl ether 131 was followed by
treatment with tetra-n-butylammonium fluoride to cleave the triethylsilyl ether.
This afforded alcohol 132 as the candidate for oxy-Cope rearrangement. The85
rearrangement was initiated by reaction with potassium hexamethyldisilazide and
the alkoxide was heated at 100°C for 20 hours to give the target structure 133 in
95% yield.
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Clive pointed out that dual alkylation of the double bond in the starting
norbornene 120 would produce the essential features of the core structure of 8
and 9.However, a feasible method for implementing this idea was not
discussed.Nevertheless, Clive succeeded in devising a route to the basic
framework of CP-225,917 using only half the number of steps in Nicolaou's
approach (vide infra).
Continuing this pursuit of a short synthesis of the bicyclic core of 8 and 9,
Armstrong has described a six-step synthesis' from cyclohexanone. The key
step of Armstrong's route is an intramolecular Mukaiyama aldol reaction.
Cyclohexanone enolate was allowed to react with diethyl ketomalonate (Scheme
39) to give alcohol 134 which was converted to the enone 135 in a two-step
procedure involving acetylation with acetic anhydride and catalytic trimethylsilyl86
trifluoromethanesulfonate,7afollowedbytreatmentwith1 ,4-
diazabicyclo[2.2.2]octane (DabcoTM). This conveniently effected elimination and
olefin isomerization in the desired manner. Extension of the side chain from 135
was accomplished by alkylation with the dimethyl acetal of 3-bromopropanal to
give 136. The kinetic enolate from 136 was quenched with trimethylsilyl chloride
to give the silyl enol ether 137 which underwent intramolecular aldol
condensation under Mukaiyama's conditions to produce 138a and 138b as a 4:1
mixture, in 52% yield.
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Aside from the brevity of Armstrong's approach, there are other
advantages to this strategy.For example, intramolecular hemiketal formation87
would distinguish between carboxyl groups at the quaternary center of 138 and is
envisioned by the authors as an extension of this work. Cyclohexenone enolates
are known to undergo y-alkylation under certain conditions, thus creating an
option for incorporation of the alkyl side chains at an early stage in the synthesis.
The main drawback to this approach is the pivotal ring-closure step, which occurs
in only modest yield and selectivity even in this abbreviated system.
Clearly, the nonadrides CP-225,917 (8) and CP-263,114 (9) have
attracted much attention in the relatively short period since their isolation. As
potential chemotherapeutic agents for treatment of heart disease and cancer,
they have been investigated from the perspectives of bioactivity, biogenesis, and
synthesis. The following chapter describes a contribution toward this latter effort.88
Chapter 5
Results and Discussion
It is evident from the foregoing account that the core bicyclo[4.3.1]deca-
1,5-diene system of CP-225,917 (8) and CP-263,114 (9) has been the subject of
multiple synthetic studies within a short time period.Each approach offers
unique advantages and drawbacks.
We have undertaken a synthetic study on this bicyclic core which hinges
upon intramolecular vinyl radical addition to an a,13-unsaturated ester (Figure
5.1).Vinyl radicals are known to be reactive intermediates with reaction rate
constants roughly three magnitudes larger than related alkyl radicals.
Moreover, the rate constant ratio of cyclization to hydrogen atom abstraction
(kcjkH) has been shown to be generally larger for vinyl radicals than related alkyl
radicale (see Figure 5.2).
CO2R
R2
CO2R
0
Figure 5.1: Radical Cylcization Approach to CP-225,91789
kc
MN.
Figure 5.2: Generalized Examples of Rate Constants kc and kH
The synthetic chemistry of vinyl radicals has been extensively developed
by Stork' and others.82 Intramolecular cyclization of vinyl radicals produced from
vinyl halides has been used previously toward the synthesis of 13-lactam
antibiotics,82spirocyclic compounds,' and lactones.88
To investigate whether this approach represented a feasible strategy for
construction of the core of CP-225,917, the a-bromocyclohexanone 139 was
selected as a target. The synthesis of 139 was envisioned via alkylation of
bromocyclohexenone with an appropriate agent, followed by chain homologation
(Scheme 40).
139
CO2R 1>
Scheme 40
141
14090
Cyclohexenone was reacted with bromine in carbon tetrachloride, then
treated with pyridine in sitd6to provide vinyl bromide 141 in 76% yield (Scheme
40). Subsequent alkylation of 141, however, proved difficult. Treatmentof 141
with lithium diisopropylamide in tetrahydrofuran, followed by addition ofn-pentyl
iodide or 5-iodo-1-pentene resulted only in decomposition withno recovery of
starting material.Addition of DMPUto the reaction mixture failed to improve
results.
a) Br2 / Cat
b) pyridine
(76%)
141
a) LDA / THE (-78°C)
b) 1/\/\/
Scheme 41
decomposition
Literature precedence has shown that cyclohexenone alkylations tend to
proceed sluggishly unless reactive alkylating agents suchas ally, bromide or
bromoacetates are used.87Furthermore, a-subtituted cyclohexenones often
show a preference for alkylation at the 4- position. Considering these factors,
and finding no prior reports of a'- alkylation of 141, the approachwas modified as
described below.
It was reasoned that Birch reductions' of 144, followed byaqueous acid
treatment would give 142, which could be brominated and homologated to afford
139 (Scheme 42). A Wittig reaction, followed by reductionwas envisioned as a
route to 144 from commercially available o-anisaldehyde (145).
Toward this end, propane-1,3-diol (146) was mono protected with tert-
butyldimethylsilyl chloride in the presence of triethylamine to give alcohol 147 in
82% yield (Scheme 43).Formation of the primary bromide 148 withOMe
145
HO
139
CO2R >
OMe
142
OMe
OP
<=3
OP
144
Scheme 42
143
91
carbon tetrabromide and triphenylphosphine, however, proceededin
disappointing yield.
H H
TBSCI, Et3N
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146 147
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As an alternative, the mesylate 149 was prepared from 147 in 94% yield
by treatment withmethanesulfonyl anhydride and triethylaminein
dichioromethane (Scheme 44).Displacement of the mesylate proceeded
smoothly by reaction with sodium iodide in acetone to give iodide 150, and the
phosphonium iodide was formed by heating 150 in the presence of
triphenylphosphine.TBS
HO
MS20, Et3N
MsO
TBS
CH2Cl2
147 149
(94%)
Ph3P, A
MeCN
(89%)
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o-Anisaldehyde (145) was reacted with the phosphonium ylid formed by
reaction of 151 with n-butyllithium to give olefin 152 as a mixture of
diastereomers (Scheme 45). The ZIE ratio of 152 was 4:1 as determined by
1HMR spectrosocopy. Since this was inconsequential to the synthetic scheme,
152 was taken on. Hydrogenation of 152 using palladium on carbon as catalyst
was successful, but these conditions unexpectedly removed the tert-butylsilyl
group, giving the free alcohol 153. Treatment of 153 with a dissolving metal
system failed to achieve any Birch reduction, returning starting material.
_TBSO
I
Ph3P
151
a) n-BuLi / THE
b)Me
CHO
153
(94%)
Na / NH3
N. R.
152
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Scheme 45
H 2, Pd/C
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Lithium in ammonia, however, provided an ideal medium for reduction of
the olefin of 152, and furnished the protected alcohol 154 in 94% yield (Scheme
46).No reduction of the aryl ring was observed under these conditions.
However, resubmission of 154 to the same conditions did provide the 1,4-
cyclohexadiene 155 in 85% yield. This two-step protocol was necessary for each
152
OMe
155
OTBSLi /NH3
t-BuOH
(94%)
OTBS
OMe
Scheme 46
154
OTBSLi /NH3,
t-BuOH
(85%)
run since simultaneous reduction of both the double bond and aromatic ring in a
single step could not be accomplished. Presumably, this is due to the initial
formation of a stabilized benzylic radical (156) lower in energy than the corre-
152
OTBS
156
TBS
e" TBS
Scheme 47
TBS
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sponding benzylic anion, which effectively halts further electron transfer (Scheme
47).
Treatment of 155 with 2M hydrochloric acid in water readily transformed
the methyl enol ether into a ketone, but produced a surprising mixture of two
products, 157 and 158 (Scheme 48).Even more surprisingly, the tert-
butyldimthylsilyl ether had remained intact in both products. Also unexpectedly,
the (3,y -enone 157 was isolated in twice the amount of the a,(3 -enone 158. The
latter benefits from additional stabilization due to conjugation and should
predominate under thermodynamic equilibration conditions. Higher temperatures
or longer reaction times resulted only in excessive decomposition.
OMe
155
2 M HCI
40°C
(64%)
Scheme 48
Treatmentof1 5 5with0.25Mhydrochloricacidin(1:1)
tetrahydrofuran/water at room temperature for 12 hours produced exclusively the
(3,y -enone 159 inquantitative yield (Scheme 49).By stirring 159 in
dichloromethane in the presence of triethylamine, an equilibrium mixure of
160:159 of roughly 2:1 was established after 3 hours that remained unchanged
after 24 hours. Residual (3,y -enone 159 could be separated and recycled in the
same manner to give a total yield for 160 of 90% from 155.OMe
155
Et3N
CH2Cl2
0.25 M HCI
THE /H2O (1:1)
rt, 12 h
(100%)
159
OH
IEt3N / CH2Cl2 (68%)
Scheme 49
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Molecular mechanics calculations predict a difference in energy of 0.5 kcal
favoring 160 over 159. This would be consistant with the observation of a 2:1
thermodynamic ratio under equilibrium conditions.It also proved possible to form
160 in 70% yield directly from 155 by heating the latter to 70°C for three hours in
tetrahydrofuran in the presence of 0.5M hydrochloric acid (Scheme 50).
Purification was then performed by chromatography.
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If 155 was heated under the above conditions for more than three hours
significant amounts of the trisubstituted olefin 161 began to form. This product96
was heavily favored thermodynamically as evidenced by the fact that 161
showed no tendency toward equilibration to other olefins with continued heating
under acidic conditions.It was found necessary to rigorously avoid traces of acid
in the storage of 160 since accompanying amounts of 159 increased over time
under such conditions.
161
The desired hydroxyenone 160 was a-brominated by addition of bromine
in carbon tetrachloride followed by pyridine-induced elimination, providing vinyl
bromide 162 in 42% yield (Scheme 51). Alcohol 162 was oxidized with N-methyl-
morpholine oxide and tetra-n-propylammonium perruthenate (TPAP) to give
aldehyde 163 which was homologated byreactionwithtrimethyl
phosphonoacetate and sodium hydride in THE to yield the a,(3-unsaturated
methyl ester 164 in good yield.
160
a) Br2 / CC14
b) pyridine
(42%)
162
NMO, TPAP,
4A ms
CH2Cl2
(75%)
163
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Scheme 51
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The key cyclization was attempted on 164 (Scheme 52) by irradiating in
the presence of tri-n-butyltin hydride and 2,2'-azobisisobutyronitrile (AIBN).
164
CO2Me
hv
Bu3SnH, AIBN
benzene
Scheme 52
165
No indication of the formation of 165 was seen in the mixture obtained
upon irradiation of 164 under these conditions.Thin layer chromatography
showed mainly baseline material with faint traces of products as streaks on the
plate.Infrared analysis revealed an ester absorption at 1722 cm-1, but no band
corresponding to a ketone or any other carbonyl was observed, suggesting that
some type of fragmentation may have occurred. The 1H NMR spectrum of the
mixture established that the n-proton of the unsaturated ketone moiety was
absent, and showed only faint resonances where the a,13-unsaturated ester
protons were present in 164. This rules out the possibility of reduction to 166via
hydrogen atom abstraction by a vinyl radical (Scheme 53).
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This result is disappointing, but not discouraging. Intramolecular radical
cyclizations are known to be strongly affected by the concentrations of both the
substrate and the hydrogen atom source.82 Temperature also plays an important
role in some reactions of this type.These represent variables yet to be
investigated in this project. Now that a route has been worked out to provide
cyclization substrate 164, material can be brought forward in quantity to perform
a systematic inquiry into this cyclization.
In addition to experimental variables, some changes in the structure of the
cyclization substrate may be worthwhile to explore. Vinyl iodide 167 would be an
alternative source of the desired intermediate vinyl radical, accessible by the
same route. Addition of another ester group as in 168 has the potential of further
stabilizing the intermediate cyclized radical 169, and for this reason may be
useful. A straightforward reduction of 164 would give the alcohol 170, which
might produce a vinyl radical less prone to possible decomposition or
rearrangement.
167
O
CO2Me
169
168
170
CO2Me99
In summary, a synthetic pathway has been established to bromoenone
164, a key substrate for the model study of our vinyl radical cyclization approach
to the core bicyclo[4.3.1]deca-1,5-diene system of CP-225,917 (8) and CP-
263,114 (9).The synthetic strategy utilizes a Birch reduction of an o-
anisaldehyde derivative and subsequent side chain elaboration to provide a,13-
unsaturated ester 164. Cyclization of 164 to the bicyclo[4.3.1]dec-1-ene 165 was
unsuccessful under the conditions attempted. However, almost all steps in the
sequence are high yielding and should allow access to large amounts of 164 for
further studies on this approach.100
Chapter 6
Experimental Section
General experimental techniques and instrumentation used in this work
are outlined in Part I, Chapter 3.
2-Bromocyclohex-2-enone (141). To a stirred solution of cyclohex-2-
enone (498 mg, 5.18 mmol) in carbon tetrachloride (3.3 mL) at 0°C was added a
solution of bromine (831 mg, 5.20 mmol) in carbon tetrachloride (3.3 mL)
dropwise over 10 min.The mixture was covered with a balloon to prevent
acetone evaporation. Pyridine (11 mL) was added, and the mixture was allowed
to warm to room temperature while stirring for 3 h, during which time a precipitate
formed. The mixture was filtered through glass wool into a stirred solution of
hydrochloric acid in water (10 mL, 2M). Layers were separated and the aqueous
portion was extracted with ethyl ether (3 x 10 mL). The combined organic layers
were washed sequentially with 2M hydrochloric acid (3 x 20 mL), 5% cupric
sulfate (3 x 20 mL), and brine, and dried (anhydrous magnesium sulfate), and
concentrated under reduced pressure at room temperature to yield 340 mg
(76%) of 141: IR (neat) 3041, 2937, 2875, 1684, 1598, 1424, 1317, 1124, 971,
915, 731 cm-1; 1H NMR (CDCI3, 400 MHz) 8 2.05 (2H, m), 2.44 (2H, m), 2.61
(2H, t, J = 5 Hz), 7.41 (1H, t, J = 3 Hz); 13C NMR (CDCI3, 75 MHz) 6 22.6, 28.3,101
38.2, 123.8, 151.1, 191.2; CIMS m/z 176 (M+1), 174, 148, 146, 135, 133, 120,
118; HRMS m/z 173.9681 (M+) (calcd for C6H7BrO: 173.9680).
TBSO
H0)
3-tert-Butyldimethylsilyloxy-1-propanol (147). To a stirred solution of
1,3-propanediol (1,191 mg, 15.65 mmol) and triethylamine (0.60 mL, 4.3 mmol)
in dichloromethane (10 mL) at room temperature was added a solution of tert-
butyldimethylsilyl chloride (475 mg, 3.15 mmol) in dichloromethane (10 mL) over
1h. The mixture was allowed to stir at room temperature overnight, and the
solvent was evaporated under reduced pressure The resulting oily mixture was
partitioned between ethyl ether (50 mL) and water (50 mL), layers were
separated and the aqueous portion was extracted with ethyl ether (3 x 50 mL).
The combined organic layers were washed with brine, dried (anhydrous
magnesium sulfate), and concentrated under reduced pressure to yield a crude
oil.The oil was purified by flash chromatography, using 20% ethyl acetate in
hexanes as eluant, to yield 490 mg (82%) of 147:IR (neat) 3356 (br), 2952,
2930, 2885, 2857, 1471, 1254, 1097, 838, 777 cm-1; 1H NMR (CDCI3, 300 MHz)
8 0.05 (6H, s), 0.89 (9H, s), 1.77 (2H, m), 2.57 (1H, bs), 3.81 (4H, m); 13C NMR
(CDCI3, 75 MHz) 8 -5.6, 18.1, 25.8, 34.1, 62.3, 62.8; CIMS m/z 191 (M+1), 175,
173, 133, 123, 109, 105, 83, 75, 69; HRMS m/z 191.1465 (M+1) (calcd for
C9H2302Si: 195.1467).
TBSO
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1-tert-Butyldimethylsiloxy-3-methanesulfonylpropane (149). To a
stirred solution of 147 (194 mg, 1.02 mmol) and triethylamine (0.27 mL, 1.9
mmol) in dichloromethane (1 mL) at 0°C was added methanesulfonyl anhydride
(220 mg, 1.2 mmol) in one portion. The mixture was allowed to warm to room
temperature and was stirred for 4.5 h.Solvent was removed under reduced
pressure and the resulting oily solid was partitioned between ethyl ether (5 mL)
and saturated aqueous ammonium chloride (5 mL). Layers were separated and
the aqueous portion was extracted with ethyl ether (3 x 5 mL). The combined
organic layers were washed with brine, dried (anhydrous magnesium sulfate),
and concentrated under reduced pressure to give an oil. The crude product was
purified by flash chromatography, using 20% ethyl acetane in hexanes as eluent,
to yield 257 mg (94%) of 149: IR (neat) 2954, 2931, 2887, 2858, 1469, 1357,
1255, 1177, 1105, 969, 943, 838, 779 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.06
(6H, s), 0.89 (9H, s), 1.94 (2H, m), 3.00 (3H, s), 3.73 (2H, t, J = 6 Hz), 4.35 (2H, t,
J = 6Hz); 13C NMR (CDCI3, 75 MHz) 8 -5.6, 18.1, 25.7, 32.0, 37.0, 58.2, 67.0;
CIMS m/z 269 (M+1), 211, 195, 174, 151, 143, 135, 113, 89, 76; HRMS mlz
269.1244 (M+1) (calcd for C10H2504SSi: 269.1243).
TBs0
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1-lodo-3--tert-butyldimethylsiloxypropane (150). To a stirred solution
of 149 (253 mg, 0.942 mmol) in acetone (2 mL) at room temperature was added
sodium iodide (2,370 mg, 15.81 mmol) in one portion. The mixture was allowed
to stir at room temperature for 8 h. Acetone (1 mL) was added and the solution
was allowed to continue stirring overnight. The mixture was partitioned between103
ethyl ether (30 mL) and water (30 mL). Layers were separated and the aqueous
portion was extracted with ethyl ether (3 x 30 mL). The combined organic layers
were washed with brine, dried (anhydrous magnesium sulfate), and concentrated
under reduced pressure to give 253 mg (89%) of 150: IR (neat) 2952, 2928,
2894, 2856, 1471, 1467, 1252, 1100, 1052, 930,835, 776 cm-1; 1H NMR (CDCI3,
300 MHz) 5 0.07 (6H, s), 0.90 (9H, s), 1.99 (2H, m), 3.28 (2H, t, J=6.8 Hz), 3.67
(2H, t, J=5.6 Hz); 13C NMR (CDCI3, 75 MHz) 8 -5.4, 3.6, 18.2, 25.8, 36.1, 62.2;
CIMS m/z 307 (M+7), 277, 215, 201, 185, 109, 93, 73, 57, 45.
_TBSO1 +)
Ph3P
3-- tert-Butyldimethylsiloxypropyltriphenylphosphonium Iodide (151).
To a stirred solution of 150 (6,047 mg, 20.14 mmol) in acetonitrile (20 mL) at
room temperature was added triphenylphosphine (5,282 mg, 20.14 mmol) in one
portion. The mixture was heated to 65°C and allowed to stir for 22 h. The
solution was cooled to room temperature and diluted with dichloromethane (35
mL). Solvent was removed under reduced pressure to give a crude solid which
was purified by flash chromatography, using 5% methanol in dichloromethane, to
provide 10.123 g (89%) of 151: IR (neat) 3050, 2951, 2928, 2855, 2183, 1466,
1437, 1253, 1108, 920, 836, 779, 726, 690 cm-1; 1H NMR (CDCI3) 8 0.00 (6H, s),
0.82 (9H, s), 1.85 (2H, m), 3.66 (2H, m), 3.82 (2H, m), 7.73 (15H, m); 13C NMR
(CDCI3) 5 -5.4, 18.1, 25.8, 25.9, 61.5, 117.4, 118.6, 130.4, 130.6, 133.5, 133.9,
135.1; FMS m/z 435 (M-I), 289, 262, 199, 183, 73; HRMS m/z 435.2273 (M-I)
(calcd for C27H3604PSi: 435.2283).104
o--(4-tert-Butyldimethylsiloxybut-1-enyl)anisole (152). To a stirred
solution of 149 (4.038 g, 7.177 mmol) in tetrahydrofuran (100 mL) at -78°C was
added a solution of n-butyllithium (6.5 mL, 1.1 M, 7.2 mmol) slowly. The mixture
was allowed to stir at -78°C for 20 min. To the mixture was added a solution of
o-anisaldehye (997 mg, 7.18 mmol) in tetrahydrofuran (15 mL) slowly. The
mixture was allowed to stir 2.5 h and let warm to room temperature. Methanol
(10 mL) and solvent removed under reduced pressure. The crude material was
mixed with 50% ethyl acetate in hexanes and filtered through a pad of Celite.
Solvent was removed under reduced pressure to give a crude oil. The oil was
purified by flash chromatography using 6% ethyl acetate in hexanes to give 1.963
g (94%) of 152:IR (neat) 3068, 2999, 2951, 2928, 2889, 2855, 1598, 1488,
1463, 1435, 1282, 1246, 1102, 1051, 1030, 939, 835, 776, 752 cm-1; 1H NMR
(CDCI3, 300 MHz) 8 0.06 (6H, s), 0.91 (9H, s), 2.49 (2H, m), 3.72 (2H, t, J = 7
Hz), 3.84 (3H, s), 5.78 (1H, m), 6.62 (1H, d, J = 12 Hz), 6.88 (1H, d, J = 8 Hz),
6.94 (1H, dd, J = 7 Hz), 7.26 (1H, m), 7.33 (1H, dd, J = 7.5, 1.6 Hz); 13C NMR
(CDCI3, 75 MHz) 8 -5.4, -5.3, 18.3, 25.9, 31.5, 32.3,55.3,55.3, 62.9, 63.1,110.2,
110.7, 119.9, 120.5, 125.9, 126.1,126.2, 126.4,127.7, 127.9, 128.0,128.8,
130.0, 156.9; CIMS trilz 293 (M+1),277, 235, 220,205,189, 161, 121,97, 84,
69; HRMS rniz 293.1929 (M+1) (calcd for C17H2902Si: 293.1937).105
o--(4-Hydroxybutyl)anisole (153). To a stirred solution of 152 (53 mg,
0.18 mmol) in methanol (1 mL) at room temperature under argon was added
10% palladium on carbon (2 mg, 0.01 mmol) in one portion. The flask was
flushed with hydrogen and covered with a hydrogen balloon. The mixture was
allowed to stir at room temperature for 2 h.The mixture was diluted with
dichloromethane (5 mL), filtered through Celite, and concentrated under reduced
pressure to give a crude oil. The oil was purified by flash chromatography, using
33% ethyl acetate in hexanes, to give 25 mg (78%) of 153: IR (neat) 3354 (br),
2934, 2860, 2835, 1595, 1493, 1460, 1241, 1118, 1051, 1027, 753 cm-1,1H NMR
(CDCI3, 300 MHz) 8 1.49 (1H, s), 1.65 (4H, m), 2.65 (2H, t, J = 7 Hz), 3.67 (2H, t,
J = 6 Hz), 3.83 (3H, s), 6.89 (2H, m), 7.15 (2H, m); 13C NMR (CDCI3, 75 MHz) 8
25.9,29.7,32.4,55.2,62.8, 110.2, 120.3, 126.9, 129.7, 130.6, 157.3; CIMS m/z
180(M+),164,163,149, 134, 121, 91; HRMS m/z 180.1149 (M+) (calcd for
C11111602: 180.1150).
o(4-tert-Butyldimethylsiloxybutyl)anisole (154). To a rapidly stirred
solution of 152 (253 mg, 0.942 mmol) and tert-butanol (3.2 mL, 33.6 mmol) in
tetrahydrofuran (4 mL) was added ammonia (25 mL), freshly distilled over
sodium.To this mixture was added lithium (720 mg, 103 mmol), in small
amounts. The mixture was allowed to stir at reflux for 4 h. Ethanol (15 mL) was106
added via syringe pump over 90 minutes. Water (15 mL) was added dropwise
and the ammonia allowed to evaporate overnight while stirring. The mixture was
partitioned between ethyl ether (50 mL) and water (20 mL).Layers were
separated and the aqueous portion was extracted with ethyl ether (5 x 35 mL).
The combined organic layers were washed with brine, dried (anhydrous
magnesium sulfate), and concentrated under reduced pressure to give a crude
oil.The oil was purified by flash chromatography using 3% ethyl acetate in
hexanes to afford 1,092 mg (94%) of154: IR(neat) 3023, 2996, 2950, 2930,
2890, 2856, 1600, 1493, 1464, 1438, 1387, 1243, 1100, 1032, 837, 775, 751 cm-
1; 1H NMR (CDCI3, 300 MHz) 8 0.06 (6H, s), 0.91 (9H, s), 1.63 (3H, m), 2.67 (2H,
t, J = 7 Hz), 3.67 (2H, t, J = 6 Hz), 3.83 (3H, s), 6.89 (2H, m), 7.15 (2H, m); 13C
NMR (CDCI3, 75 MHz) 8 -5.3, 18.3, 25.9, 25.9, 29.8, 32.7, 55.1, 63.1, 110.1,
120.2, 126.8, 129.7, 131.0, 157.4; CIMS m/z 294 (M+), 279, 237, 220, 205, 191,
163, 149, 121, 89, 75, 69; HRMS m/z 295.2089 (M+1) (calcd for Ci7H3102Si:
295.2093).
OMe
2-(4-tert-ButyldimethylsiloxybutyI)-1-methoxy-1,4-cyclohexadiene (155).
To a rapidly stirred mixture of154(1,092 mg, 3.707 mmol) and tert-butanol (3.2
mL, 33.6 mmol) in tetrahydrofuran (4 mL) was added ammonia (25 mL), freshly
distilled over sodium. To this mixture was added lithium (560 mg, 80 mmol), in
small amounts. The mixture was allowed to stir at reflux for 4.5 h.Ethanol (25
mL) was added via syringe pump over 120 minutes. Water (15 mL) was added
dropwise and the ammonia allowed to evaporate overnight while stirring. The107
mixture was partitioned between ethyl ether (50 mL) and water (20 mL). Layers
were separated and the aqueous portion was extracted with ethyl ether (5 x 35
mL). The combined organic layers were washed with brine, dried (anhydrous
magnesium sulfate), and concentrated under reduced pressure to give 1,000 mg
(85%) of 155: IR (neat) 3029, 2949, 2929, 2887, 2856, 1640, 1467, 1254, 1205,
1140, 1100, 1011, 838, 775 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.04 (6H, s), 0.89
(9H, s), 1.40-1.50 (4H, m), 2.11 (2H, t, J = 9 Hz), 2.72 (2H, t, J = 7 Hz), 2.80 (2H,
t, J = 7 Hz), 3.50 (3H, s), 3.61 (2H, t, J = 6 Hz), 5.66 (2 H, s); 13C NMR (CDCI3,
75 MHz) 8 -5.4, 18.3, 23.7, 25.9, 25.9, 28.4,30.1,32.6,55.9,63.0, 115.2, 123.1,
124.5, 145.3; CIMS m/z 296 (M+), 295, 281.265,239,237,207, 197, 184, 175,
163, 149, 137, 133, 121, 109, 93, 91; HRMS m/z 296.2169 (M+) (calcd for
Ci7H3202Si: 296.2172).
6-(4-tert-Butyldimethylsiloxybutyl)cyclohex-3-enone (157). To a
stirred amount of 155 (5.0 mg, 0.017 mmol) was added an aqueous solution of
hydrochloric acid (1 mL, 2 M). The mixture was warmed to 40°C and allowed to
stir for 3 h. The mixture was cooled to room temperature and ethyl ether (1 mL)
was added. Layers were separated and the aqueous portion was extracted with
ethyl ether (3 x 1 mL). The combined organic layers were washed with brine,
dried (anhydrous magnesium sulfate), and concentrated under reduced pressure.
The crude oil was purified by flash chromatography using 10% ethyl acetate in
hexanes to give 2 mg (43%) of 157: IR (neat) 2960, 2930, 2995, 2857, 1717,
1255, 1099, 836, 775 cm-1; 1H NMR (CDCI3, 300 MHz) 8 0.04 (6H, s), 0.89 (9H,108
s), 1.40-1.50 (4H, m), 2.15 (1H, m), 2.59 (2H, m), 2.90 (2H, m), 3.60 (2H, t, J = 6
Hz).
6-(4-Hydroxybutyl)cyclohex-3-enone (159). To a stirred solution of 155
(33 mg, 0.11 mmol) in a mixture of tetrahydrofuran (2.5 mL) and water (5 mL)
was added p-toluenesulfonic acid monohydrate (19 mg, 0.10 mmol) in one
portion. The mixture was allowed to stir for 4 h at room temperature. Most of the
tetrahydrofuran was evaporated under reduced pressure and the resulting to give
a crude oil.The oil was purified by flash chromatography using 33% ethyl
acetate in hexanes to to yield 18 mg (100%) of 159: IR (neat) 3390 (br), 3031,
2929, 2858, 1708, 1654, 1440, 1403, 1377, 1306, 1217, 1061, 1033 cm-1; 1H
NMR (CDCI3, 300 MHz) 5 1.33 (3H, m), 1.54 (2H, m), 1.80 (1H, m), 2.11 (1H, m),
2.55 (2H, m), 2.85 (2H, m), 3.61 (2H, t, J. 7 Hz), 5.72 (2H, m); 13C NMR (CDCI3,
75 MHz) 8 23.3, 28.7, 32.5, 32.5, 40.4, 47.9, 62.4, 124.3, 126.4, 211.7; CIMS m/z
168 (M+), 151, 150, 133, 123, 98, 96, 86, 84, 79, 70, 67; HRMS m/z 168.1149
(M+) (calcd for C10t-11602: 168.1150).
6-(4-Hydroxybutyl)cyclohex-2-enone (160). To a stirred solution of 155
(7.3 mg, 0.024 mmol) in tetrahydrofuran (0.5 mL) was added an aqueous solution109
of hydrochloric acid (0.5 mL, 0.5 M). The mixture was allowed to stir for at room
temperature overnight.Ethyl ether (1 mL) was added and layers were
separated. The aqueous portion was extracted with ethyl ether (3 x 1 mL). The
combined organic layers were washed with brine, dried (anhydrous magnesium
sulfate), and concentrated under reduced pressure to yield 4 mg (100%) of 160:
IR (neat) 3410 (br), 2932, 2862, 1669, 1454, 1426, 1388, 1220, 1060 cm-1; 1H
NMR (CDCI3, 400 MHz) 8 1.37 (3H, m), 1.55 (2H, m), 1.80 (2H, m), 2.10 (2H, m),
2.26 (1H, m), 2.35 (2H, m), 3.62 (2H, t, J = 5 Hz), 5.94 (1H, dt, J = 8, 1 Hz), 6.91
(1H, m); 13C NMR (CDCI3, 100 MHz) 8 23.1, 25.1, 27.8, 28.8, 32.6, 46.5, 62.5,
129.5, 149.6, 202.0; CIMS m/z 169 (M+1), 151, 133, 96, 84; HRMS m/z
169.1229 (M+1) (calcd for C10H1702: 169.1229).
2-Bromo-6-(4-hydroxybutyl)cyclohex-2-enone (162).To a stirred
solution of 160 (33 mg, 0.20 mmol) in carbon tetrachloride (0.3 mL) at 0°C was
added an solution of bromine (0.24 mL, 1 M, 0.24 mmol) in carbon tetrachloride
dropwise over 5 min. Pyridine (0.20 mL) was added dropwise, and the mixture
allowed to warm to room temperature and stir 2.5 h. The mixture was filtered
through glass wool into an aqueous solution of hydrochloric acid (1 mL, 2 M).
Layers were separated and the aqueous portion was extracted with
dichloromethane (2 x 1 mL). The combined organic layers were washed with 2
M hydrochloric acid (3 x 1 mL) and brine, dried (anhydrous magnesium sulfate),
and concentrated under reduced pressure. The crude oil was purified by flash
chromatography using 50% ethyl acetate in hexanes to give 20 mg (42%) of 162:110
IR (neat) 3360 (br), 2932, 2862, 1687, 1605, 1453, 1421, 1326, 1063, 1031 cm-
1; 1H NMR (CDCI3, 300 MHz) 8 1.40 (3H, m), 1.60 (2H, m), 1.70 (1H, m), 1.85
(1H, m), 2.15 (1H, m), 2.40 (3H, m), 3.65 (2H, t, J = 6 Hz), 7.35 (1H, t, J = 4 Hz);
13C NMR (CDCI3, 75 MHz) 8 21.7, 23.1, 27.4, 29.2, 32.6, 47.3, 62.6, 129.5,
150.0, 193.5; CIMS m/z 248 (M+1), 195, 181, 169, 167, 123, 109, 96; HRMS m/z
248.0969 (M+1) (calcd for C1 oH16Br02: 248.0971).
CHO
2-Bromo-6-(4-oxobutyl)cyclohex-2-enone (163). To a stirred mixture of
162 (21 mg, 0.085 mmol) and 4A molecular sieves in dichloromethane (0.7 mL)
at room temperature was added N-methylmorpholine-N-oxide (15 mg, 0.13
mmol) in one portion.To the mixture was added tetrapropylammonium
perruthenate (5 mg, 0.1 mmol) in one portion. The mixture allowed to stir at
room temperature 45 min and diluted with ethyl ether (2 mL). The mixture was
filtered through a plug of silica and concentrated under reduced pressure. The
crude oil was purified by flash chromatography using 33% ethyl acetate in
hexanes to give 15 mg (75%) of 163: IR (neat) 2929, 2861, 2723, 1720, 1686,
1606, 1455, 1420, 1388, 1323, 1128 cm-1; 1H NMR (CDCI3, 300 MHz) 6 1.50
(2H, m), 1.65 (2H, m), 1.88 (2H, m), 2.15 (2H, m), 2.4-2.5 (4H, m), 7.36 (1H, t, J
= 4 'Hz), 9.77 (1H, t, J = 1 Hz); 13C NMR (CDCI3, 75 MHz) 6 19.4, 27.4, 27.7,
29.1, 38.8, 43.8, 129.5, 150.0, 192.1, 202.1; CIMS m/z 245 (M+), 231, 229, 227,
211, 209, 201, 199, 187, 185, 176, 174, 149, 147, 121, 119, 83, 81; HRMS m/z
247.0160 (M+1) (calcd for C10H1481Br02: 247.0157).CO2Me
111
Methyl 6- (2- Oxo- 3- bromocyclohex- 3- enyl)- hex -2 -ene (164). To a 60%
suspension of sodium hydride in mineral oil (4 mg, 0.099 mmol) was added a
solution of trimethylphosphonoacetate (7 mg, 0.038 mmol) in tetrahydrofuran (0.3
mL) at room temperature. The mixture was allowed to stir at room temperature
15 min. To the mixture was added a solution of 163 (8 mg, 0.033 mmol) in
tetrahydrofuran (0.4 mL).The mixture was allowed to stir 30 min at room
temperature.To the mixture was added a saturated aqueous solution of
ammonium chloride (1 mL) and ethyl ether (1 mL). Layers were separated and
the aqueous portion was extracted with diethyl ether (3 x 1 mL). The combined
organic layers were washed with brine, dried (anhydrous magnesium sulfate),
and concentrated under reduced pressure. The crude oil was purified by flash
chromatography using 20% ethyl acetate in hexanes to give 9 mg (90%) of 164:
IR (neat) 2924, 2855, 1722, 1687, 1436, 1317, 1268, 1199, 1174, 1033 cm-1; 1H
NMR (CDCI3, 300 MHz) 8 1.50 (3H, m), 1.84 (2H, m), 2.1 (1H, m), 2.22 (2H, m),
2.46 (3H, m), 3.73 (3H, s), 5.86 (1H, d, J = 19 Hz), 6.95 (1H, m), 7.35 (1H, t, J
4 Hz) ; 13C NMR (CDCI3, 75 MHz) 8 27.4, 27.7, 29.2, 30.9, 32.1, 47.2, 51.4,
121.3, 129.5, 148.8, 149.9, 172.7, 193.3; CIMS m/z 301 (M+), 271, 269, 251,
223, 191, 198, 173, 171, 163, 145, 131, 119, 96, 83; HRMS m/z 303.0412 (M+1)
(calcd for Ci3F11881Br03: 303.0419).
Attempted radical cyclization of 164.. To a stirred solution of 164 (2.0
mg, 0.0066 mmol) and tri-n-butyltin hydride (2.1 mg, 0.0073 mmol) in dry112
benzene (0.4 mL) was added 2,2'-azobisisobutyronitrile (2.0 mg, 0.012 mmol) in
one portion. The stirred mixture was irradiated with a 250-W heat lamp at reflux
for 4 h. The mixture was allowed to cool, and ethyl ether (2 mL) and a saturated
aqueous solution of sodium fluoride (2 mL) were added. The mixture was stirred
vigorously for 1h and layers were separated.The aqueous portion was
extracted with diethyl ether (3 x 1 mL) and the combined organic layers were
washed with brine, dried (anhydrous magnesium sulfate), and concentrated
under reduced pressure. The crude oil was analyzed.113
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CONCLUSION
Substantial progress was made toward the synthetic routes of two
nonadrides, byssochlamic acid and CP-225,917.In the byssochlamic acid
synthesis, a novel regioselective, enzymatic hydrolysis was carried out, making
possible a critical differentiation between two methyl esters of a cyclobutene
intermediate. The synthetic scheme to a substrate for a model study of the
bicyclic core of CP-225,917 has been completed.It utilizes readily available,
inexpensive starting materials and facilitates the production of substantial
quantities of the substrate for systematic studies on the proposed vinyl radical
cyclization.119
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APPENDIX128
SUPPLEMENTARY CRYSTALLOGRAPYHIC INFORMATION ON
CARBOXYLATE SALT 48
48Table 1. Crystal Data and Structure Refinement for 48
Empirical Formula
Formula Weight
Temperature
Wavelength
Crystal System
Space Group
Unit Cell Dimensions
Volume
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal Size
Theta Range for Data Collection
Index Ranges
Reflections Collected
Independent Reflections
Absorption Correction
Max. and Min. Transmission
Refinement Method
Data / Restraints / Parameters
Goodness-of-fit on F2
Final R indices [I >2sigma(I)]
R Indices (all data)
Absolute Structure Parameter
Extinction Coefficient
Largest Diff. Peak and Hole
C21H31 N 04
361.47
298(2) K
1.54178 A
Monoclinic
C2
a = 35.2023(19)A
b = 6.0715(4)A
c = 10.4710(9)A
2193.7(3)A3
4
1.094 Mg/m3
0.601 mm-1
784
0.60 x 0.40 x 0.10 mm3
4.56 to 57.44 °.
-28<=h<=38, -5<=k<=6, -11<=k=11
2617
2358 [R(int) = 0.0206]
Empirical (psi scans)
0.9423 and 0.7143
Full-matrix least-squares on F2
2358 / 1 / 271
1.059
R1 = 0.0440, wR2 = 0.1145
R1 = 0.0502, wR2 = 0.1238
0.0(4)
0.0042(4)
0.171 and -0.135 e.A-3
129
a= 90°.
r3= 101.414(6)°.
y = 90°.130
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement
parameters (A2x 103) for 48
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
x y z U(eq)
0(1) 2940(1) 2042(4) 5007(2) 62(1)
0(2) 3320(1) -817(4) 5728(2) 70(1)
0(3) 3686(1) 1163(5) 3390(2) 88(1)
0(4) 4280(1) 2658(5) 3860(2) 86(1)
C(11) 3263(1) 1200(6) 5513(3) 54(1)
C(12) 3593(1) 2731(5) 5935(3) 57(1)
C(13) 3626(1) 4032(7) 7187(3) 72(1)
C(14) 4026(1) 5026(8) 7400(4) 87(1)
C(15) 4149(1) 4931(7) 6092(4) 78(1)
C(16) 3884(1) 3216(6) 5346(3) 62(1)
C(17) 3929(1) 2212(7) 4103(3) 70(1)
C(18) 4104(1) 7024(10)8222(5) 112(2)
C(19) 4492(2) 7937(12)8466(6) 142(2)
C(21) 4148(2) 2812(12)1496(5) 125(2)
C(22) 4389(2) -652(11)2653(6) 132(2)
C(23) 4812(1) 2697(13)2856(5) 135(2)
C(24) 4403(1) 1787(9) 2688(5) 95(1)
C(31) 2531(1) 1249(6) 7961(3) 59(1)
C(32) 2698(1) 2602(8) 8984(4) 81(1)
C(33) 3021(1) 1865(10) 9862(4) 95(1)
C(34) 3179(1) -151(9) 9747(4) 83(1)
C(35) 3012(1) -1501(8) 8747(4) 83(1)
C(36) 2686(1) -836(7) 7866(3) 72(1)
C(37) 2181(1) 2067(6) 7004(3) 61(1)
C(38) 1799(1) 1197(7) 7271(3) 76(1)
N 2203(1) 1443(5) 5636(2) 56(1)Table 3. Bond Lengths [A] for 48
O(1) -C(11) 1.263(4)
0(2)-C(11) 1.254(4)
0(3)-C(17) 1.201(4)
0(4)-C(17) 1.338(4)
O(4) -C(24) 1.477(5)
C(11)-C(12) 1.484(4)
C(12)-C(16) 1.330(4)
C(12)-C(13) 1.515(5)
C(13)-C(14) 1.508(5)
C(14)-C(18) 1.481(7)
C(14)-C(15) 1.516(5)
C(15)-C(16) 1.509(5)
C(16)-C(17) 1.474(5)
C(18)-C(19) 1.448(6)
C(21)-C(24) 1.519(7)
C(22)-C(24) 1.482(8)
C(23)-C(24) 1.521(6)
C(31)-C(32) 1.385(5)
C(31)-C(36) 1.390(5)
C(31)-C(37) 1.510(4)
C(32) -C(33) 1.387(6)
C(33) -C(34) 1.360(7)
C(34) -C(35) 1.368(6)
C(35) -C(36) 1.381(5)
C(37)-N 1.498(4)
C(37) -C(38) 1.522(4)
N-H (OA) 0.92(3)
N-H(OB) 1.08(5)
N-H(OC) 1.12(5)
131Table 4. Bond Angles [O] for 48
C(17)-0 (4)-C (24) 121.3(3)
0(2)-C(11)-0(1) 124.7(3)
0(2)-C(11)-C(12) 118.1(3)
0(1)-C(11)-C(12) 117.2(3)
C(16)-C(12)-C(11) 129.0(3)
C(16)-C(12)-C(13) 110.5(3)
C(11)-C(12)-C(13) 120.5(3)
C(14)-C(13)-C(12) 104.4(3)
C(18)-C(14)-C(13) 118.3(4)
C(18)-C(14)-C(15) 120.2(4)
C(13)-C(14)-C(15) 106.0(3)
C(16)-C(15)-C(14) 103.7(3)
C(12)-C(16)-C(17) 123.1(3)
C(12)-C(16)-C(15) 111.5(3)
C(17)-C(16)-C(15) 125.4(3)
0(3)-C(17)-0(4) 124.1(3)
0(3)-C(17)-C(16) 125.5(3)
0(4)-C(17)-C(16) 110.5(3)
C(19)-C(18)-C(14) 118.4(5)
O(4)- C(24) -C(22) 111.4(4)
0(4)-C(24)-C (21) 108.3(4)
C (22)-C (24)-C (21) 112.2(5)
O(4)- C(24) -C(23) 101.5(4)
C(22)-C(24)-C(23) 113.0(5)
C(21)-C(24)-C(23) 109.8(5)
C(32)-C(31)-C(36) 118.9(3)
C(32)-C(31)-C(37) 118.9(3)
C(36)-C(31)-C(37) 122.2(3)
C(31)-C(32)-C(33) 119.2(4)
C(34)-C(33)-C(32) 121.8(4)
C(33)-C(34)-C(35) 119.1(4)
C(34)-C(35)-C(36) 120.7(4)
C(35)-C(36)-C(31) 120.3(4)
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Table 4 (cont.) Bond Angles [0] for 48
N-C(37)-C(38) 107.5(3)
N-C(37)-C(31) 111.3(2)
C(31)-C(37)-C(38) 113.5(3)
H(0A)-N-H(OB) 107(3)
H(0A)-N-H(OC) 110(3)
H(OB)-N-H(OC) 116(3)
H(0A)-N-C(37) 109.6(18)
H(OB)-N-C(37) 104(2)
H(OC)-N-C(37) 111.0(17)
Symmetry transformations used to generate equivalent atoms:Table 5.Anisotropic Displacement Parameters (A2x 103) for 48
The anisotropic displacement factor exponent takes the form:
-2 72[ h2a*2U11 ++ 2 h k a* b* U12 ]
AtomUll U22 U33 U23 U13
0(1) 44(1) 62(1) 79(1) 9(1) 11(1)
0(2) 64(1) 52(2) 88(2) 7(1) 2(1)
0(3) 69(1) 100(2) 97(2) -35(2) 25(1)
0(4) 57(1) 106(2) 100(2) -26(2) 31(1)
C(11) 49(2) 54(2) 60(2) 1(2) 13(1)
C(12) 45(2) 56(2) 70(2) -4(2) 6(1)
C(13) 68(2) 77(3) 72(2) -15(2) 13(2)
C(14) 78(2) 91(3) 93(3) -28(2) 14(2)
C(15) 55(2) 83(3) 94(3) -18(2) 12(2)
C(16) 46(2) 62(2) 77(2) -14(2) 9(1)
C(17) 48(2) 72(2) 90(2) -12(2) 16(2)
C(18) 100(3) 124(4) 108(3) -39(3) 12(2)
C(19) 115(4) 151(5) 156(5) -58(4) 13(3)
C(21) 128(4) 147(5) 108(3) -18(4) 43(3)
C(22) 141(5) 103(4) 174(6) -29(4) 81(4)
C(23) 87(3) 181(6) 156(4) -28(5) 68(3)
C(24) 78(2) 106(4) 111(3) -33(3) 45(2)
C(31) 60(2) 57(2) 62(2) -3(2) 17(1)
C(32) 73(2) 81(3) 87(2) -25(2) 14(2)
C(33) 83(3) 109(4) 86(3) -19(3) 1(2)
C(34) 71(2) 98(4) 75(2) 10(3) 6(2)
C(35) 82(2) 88(3) 80(2) 6(2) 19(2)
C(36) 83(2) 66(2) 65(2) -2(2) 9(2)
C(37) 62(2) 54(2) 70(2) -3(2) 19(1)
C(38) 63(2) 89(3) 82(2) 4(2) 28(2)
N 48(1) 54(2) 67(2) 1(1) 14(1)
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Table 6. Hydrogen Coordinates ( x 104) and Isotropic Displacement
Parameters (A2x 103) for 48
x y z U (eq)
H(13A) 3431(6) 5170(4) 7099(4) 113(4)
H(13B) 3600(1) 3080(3) 7900(2) 113(4)
H(14) 4221(8) 3680(6) 8010(3) 113(4)
H(15A) 4112(1) 6400(5) 5640(14) 113(4)
H(15B) 4428(9) 4480(15) 6197(5) 113(4)
H(18A) 3906(6) 8310(4) 7769(12) 113(4)
H(18B) 4031(3) 6650(13) 9160(2) 113(4)
H(19A) 4686(6) 6800(4) 8990(3) 152(6)
H(19B) 4497(3) 9390(5) 9000(3) 152(6)
H(19C) 4574(5) 8280(5) 7580(3) 152(6)
H(21A) 4249(7) 2340(5) 660(3) 152(6)
H(21B) 4157(7) 4540(5) 1584(15) 152(6)
H(21C) 3861(9) 2270(5) 1423(19) 152(6)
H (22A) 4533(9) -1260(2) 3520(3) 152(6)
H (22B) 4516(9) -1210(2) 1920(3) 152(6)
H (22C) 4108(8) -1161(19) 2490(3) 152(6)
H (23A) 4966(6) 2160(5) 3650(3) 152(6)
H (23B) 4804(1) 4280(5) 2880(3) 152(6)
H(23C) 4925(6) 2240(5) 2140(3) 152(6)
H(32) 2585(6) 4110(8) 9091(7) 113(4)
H(33) 3123(6) 2700(5) 10490(3) 113(4)
H(34) 3396(11) -600(2) 10330(3) 113(4)
H(35) 3123(6) -2940(8) 8655(7) 113(4)
H(36) 2573(6) -1770(5) 7220(3) 113(4)
H(37) 2176(1) 3850(9) 7062(4) 113(4)
H (38A) 1786(4) -440(5) 7130(3) 152(6)
H(38B) 1578(6) 1920(4) 6660(3) 152(6)
H(38C) 1781(4) 1540(5) 8200(3) 152(6)
H (OA) 2450(10) 1680(6) 5500(3) 68(9)136
Table 6. (cont) Hydrogen Coordinates ( x 104) and Isotropic Displacement
Parameters (A2x 103) for 48
H(OB) 2016(12) 2630(8) 5050(4) 100(12)
H(OC) 2123(9) -330(8) 5440(3) 78(11)137
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